Authors,Title,Year,Source title,Volume,Issue,Art. No.,Page start,Page end,Page count,Cited by,DOI,Link,Document Type,Source,EID
"Poordad, F., Felizarta, F., Asatryan, A., Sulkowski, M.S., Reindollar, R.W., Landis, C.S., Gordon, S.C., Flamm, S.L., Fried, M.W., Bernstein, D.E., Lin, C.-W., Liu, R., Lovell, S.S., Ng, T.I., Kort, J., Mensa, F.J.","Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment",2017,"Hepatology","66","2",,"389","397",,1,10.1002/hep.29081,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017563535&doi=10.1002%2fhep.29081&partnerID=40&md5=1fd60e49160a38d7c945ab09a6749fd4",Article,Scopus,2-s2.0-85017563535
"Gordon, S.C., Trudeau, S., Li, J., Zhou, Y., Rupp, L.B., Holmberg, S.D., Moorman, A.C., Spradling, P.R., Teshale, E., Boscarino, J.A., Daida, Y.G., Schmidt, M.A., Lu, M.","Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States",2017,"Journal of Clinical Gastroenterology",,,,"","",,,10.1097/MCG.0000000000000872,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85025599528&doi=10.1097%2fMCG.0000000000000872&partnerID=40&md5=7ca76da46d4f00d6c6481e7d963c31f0",Article in Press,Scopus,2-s2.0-85025599528
"Lu, M., Chacra, W., Rabin, D., Rupp, L.B., Trudeau, S., Li, J., Gordon, S.C.","Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records",2017,"Clinical Epidemiology","9",,,"369","376",,,10.2147/CLEP.S136134,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026489027&doi=10.2147%2fCLEP.S136134&partnerID=40&md5=8205e9278c0ffaebd1e3f1f287e7eb3e",Article,Scopus,2-s2.0-85026489027
"Spradling, P.R., Xing, J., Rupp, L.B., Moorman, A.C., Gordon, S.C., Lu, M., Teshale, E.H., Boscarino, J.A., Schmidt, M.A., Daida, Y.G., Holmberg, S.D.","Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015",2017,"Journal of Clinical Gastroenterology",,,,"","",,,10.1097/MCG.0000000000000857,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020287932&doi=10.1097%2fMCG.0000000000000857&partnerID=40&md5=0dca75170185ea9fbc2fa1ff71887c9b",Article in Press,Scopus,2-s2.0-85020287932
"Li, J., Gordon, S.C., Rupp, L.B., Zhang, T., Trudeau, S., Holmberg, S.D., Moorman, A.C., Spradling, P.R., Teshale, E.H., Boscarino, J.A., Daida, Y.G., Schmidt, M.A., Lu, M., Xing, J., Zhong, Y., Nerenz, D.R., Lamerato, L., Akkerman, N., Oja-Tebbe, N., Zhou, Y., Daar, Z.S., Smith, R.E., Trinacty, C.M., Wong, C.P., Donald, J.L., Keast, E.M.","Long-term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B",2017,"Journal of Gastroenterology and Hepatology (Australia)","32","6",,"1250","1257",,,10.1111/jgh.13667,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020106682&doi=10.1111%2fjgh.13667&partnerID=40&md5=11cbd1e4aaeb32d96c6a285ace1119c2",Article,Scopus,2-s2.0-85020106682
"Bourlière, M., Gordon, S.C., Flamm, S.L., Cooper, C.L., Ramji, A., Tong, M., Ravendhran, N., Vierling, J.M., Tran, T.T., Pianko, S., Bansal, M.B., De Lédinghen, V., Hyland, R.H., Stamm, L.M., Dvory-Sobol, H., Svarovskaia, E., Zhang, J., Huang, K.C., Subramanian, G.M., Brainard, D.M., McHutchison, J.G., Verna, E.C., Buggisch, P., Landis, C.S., Younes, Z.H., Curry, M.P., Strasser, S.I., Schiff, E.R., Reddy, K.R., Manns, M.P., Kowdley, K.V., Zeuzem, S.","Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection",2017,"New England Journal of Medicine","376","22",,"2134","2146",,1,10.1056/NEJMoa1613512,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020200062&doi=10.1056%2fNEJMoa1613512&partnerID=40&md5=d4838f5b58499db56d4a1d096adb0e56",Article,Scopus,2-s2.0-85020200062
"Kanwal, F., Bacon, B.R., Beste, L.A., Brill, J.V., Gifford, A.L., Gordon, S.C., Horberg, M.A., Manthey, J.G., Reau, N., Rustgi, V.K., Younossi, Z.M.","Hepatitis C Virus Infection Care Pathway—A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group",2017,"Gastroenterology","152","6",,"1588","1598",,,10.1053/j.gastro.2017.03.039,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018799467&doi=10.1053%2fj.gastro.2017.03.039&partnerID=40&md5=e5c021a8493fc9433936628587a39c08",Article,Scopus,2-s2.0-85018799467
"Gonzalez, H.C., Jafri, S.-M., Gordon, S.C.","Management of Acute Hepatotoxicity Including Medical Agents and Liver Support Systems",2017,"Clinics in Liver Disease","21","1",,"163","180",,,10.1016/j.cld.2016.08.012,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84995897755&doi=10.1016%2fj.cld.2016.08.012&partnerID=40&md5=a3f0650a94452ed01d0c79493952d628",Review,Scopus,2-s2.0-84995897755
"Younossi, Z., Gordon, S.C., Ahmed, A., Dieterich, D., Saab, S., Beckerman, R.","Treating Medicaid Patients with Hepatitis C: Clinical and Economic Impact",2017,"American Journal of Managed Care","23","2",,"107","112",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015359559&partnerID=40&md5=2b10bc721fb555150c430219aa98a05d",Article,Scopus,2-s2.0-85015359559
"Foster, M.A., Xing, J., Moorman, A.C., Boscarino, J., Gordon, S.C., Lu, M., Rupp, L., Schmidt, M.A., Trinacty, C.M., Xu, F., Holmberg, S.D., Spradling, P.R.","Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study",2016,"Digestive Diseases and Sciences","61","12",,"3469","3477",,,10.1007/s10620-016-4269-0,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84981218308&doi=10.1007%2fs10620-016-4269-0&partnerID=40&md5=57261e6636212f31e91a0f50f43d8cd6",Article,Scopus,2-s2.0-84981218308
"Gane, E.J., Kowdley, K.V., Pound, D., Stedman, C.A.M., Davis, M., Etzkorn, K., Gordon, S.C., Bernstein, D., Everson, G., Rodriguez-Torres, M., Tsai, N., Khalid, O., Yang, J.C., Lu, S., Dvory-Sobol, H., Stamm, L.M., Brainard, D.M., McHutchison, J.G., Tong, M., Chung, R.T., Beavers, K., Poulos, J.E., Kwo, P.Y., Nguyen, M.H.","Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial",2016,"Gastroenterology","151","5",,"902","909",,8,10.1053/j.gastro.2016.07.038,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994854365&doi=10.1053%2fj.gastro.2016.07.038&partnerID=40&md5=16d26455a078c894e5d24b5acede33ef",Article,Scopus,2-s2.0-84994854365
"Spradling, P.R., Xing, J., Rupp, L.B., Moorman, A.C., Gordon, S.C., Teshale, E.T., Lu, M., Boscarino, J.A., Trinacty, C.M., Schmidt, M.A., Holmberg, S.D., Teshale, E.H., Xu, F., Xing, J., Zhong, Y., Nerenz, D.R., Lamerato, L., Li, J., Akkerman, N., Oja-Tebbe, N., Zhou, Y., Zhang, T., Daar, Z.S., Smith, R.E., Lewis, M., Trinacty, C.M., Daida, Y.G., Wong, C.P., Donald, J.L., Keast, E.M.","Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings",2016,"Clinical Infectious Diseases","63","9",,"1205","1208",,3,10.1093/cid/ciw516,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994509579&doi=10.1093%2fcid%2fciw516&partnerID=40&md5=f299841ba1b6f4bfc990a73961198194",Article,Scopus,2-s2.0-84994509579
"Spradling, P.R., Xing, J., Rupp, L.B., Moorman, A.C., Gordon, S.C., Teshale, E.T., Lu, M., Boscarino, J.A., Schmidt, M.A., Trinacty, C.M., Holmberg, S.D., Holmberg, S.D., Teshale, E.H., Spradling, P.R., Moorman, A.C., Xing, J., Zhong, Y., Gordon, S.C., Nerenz, D.R., Lu, M., Lamerato, L., Li, J., Rupp, L.B., Akkerman, N., Oja-Tebbe, N., Zhang, T., Trudeau, S., Zhou, Y., Boscarino, J.A., Daar, Z.S., Smith, R.E., Daida, Y.G., Trinacty, C.M., Wong, C.P., Schmidt, M.A., Donald, J.L., Keast, E.M.","Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006–2013",2016,"Alimentary Pharmacology and Therapeutics","44","10",,"1080","1089",,1,10.1111/apt.13802,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994851018&doi=10.1111%2fapt.13802&partnerID=40&md5=767d133ff778b58bc22bb7ff3edbca24",Article,Scopus,2-s2.0-84994851018
"Kwo, P.Y., Poordad, F., Asatryan, A., Wang, S., Wyles, D.L., Hassanein, T., Felizarta, F., Sulkowski, M.S., Gane, E., Maliakkal, B., Overcash, J.S., Gordon, S.C., Muir, A.J., Aguilar, H., Agarwal, K., Dore, G.J., Lin, C.-W., Liu, R., Lovell, S.S., Ng, T.I., Kort, J., Mensa, F.J.","Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis",2016,"Journal of Hepatology",,,,"","",,,10.1016/j.jhep.2017.03.039,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019575184&doi=10.1016%2fj.jhep.2017.03.039&partnerID=40&md5=4bd71db7b0beae970386faf3c5d35bc0",Article in Press,Scopus,2-s2.0-85019575184
"Younossi, Z.M., Park, H., Dieterich, D., Saab, S., Ahmed, A., Gordon, S.C.","Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care",2016,"Medicine","95","41",,"e5048","",,2,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011085832&partnerID=40&md5=e03ca1078f806a62243b26e70c8961e4",Review,Scopus,2-s2.0-85011085832
"Teshale, E.H., Xing, J., Moorman, A., Holmberg, S.D., Spradling, P.R., Gordon, S.C., Rupp, L.B., Lu, M., Boscarino, J.A., Trinacity, C.M., Schmidt, M.A., Xu, F., Xu, F., Nerenz, D.R., Lu, M., Lamerato, L., Li, J., Akkerman, N., Oja-Tebbe, N., Zhang, T., Zhou, Y., Larkin, D., Daar, Z.S., Lewis, M., Smith, R.E., Trinacty, C.M., Daida, Y., Wong, C., Donald, J.L., Keast, E.M.","Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006–2013",2016,"Journal of Viral Hepatitis","23","10",,"748","754",,1,10.1111/jvh.12548,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84987849896&doi=10.1111%2fjvh.12548&partnerID=40&md5=b66820491ac2ffcda0c3a42b1e7c8eef",Article,Scopus,2-s2.0-84987849896
"Lok, A.S., Pan, C.Q., Han, S.-H.B., Trinh, H.N., Fessel, W.J., Rodell, T., Massetto, B., Lin, L., Gaggar, A., Subramanian, G.M., McHutchison, J.G., Ferrari, C., Lee, H., Gordon, S.C., Gane, E.J.","Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B",2016,"Journal of Hepatology","65","3",,"509","516",,13,10.1016/j.jhep.2016.05.016,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84991093310&doi=10.1016%2fj.jhep.2016.05.016&partnerID=40&md5=c8cd3fd9f5b234fc7dffe956c89c4d28",Article,Scopus,2-s2.0-84991093310
"Lu, M., Li, J., Rupp, L.B., Holmberg, S.D., Moorman, A.C., Spradling, P.R., Teshale, E.H., Zhou, Y., Boscarino, J.A., Schmidt, M.A., Lamerato, L.E., Trinacty, C., Trudeau, S., Gordon, S.C., Xing, J., Tong, C., Nerenz, D.R., Akkerman, N., Oja-Tebbe, N., Zhang, T., Daar, Z.S., Smith, R.E., Parker, J.V., Donald, J.L., Keast, E.M.","Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma",2016,"Journal of Viral Hepatitis","23","9",,"718","729",,5,10.1111/jvh.12538,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84980329350&doi=10.1111%2fjvh.12538&partnerID=40&md5=16495050f9e2d25f0fae976dfbfbd290",Article,Scopus,2-s2.0-84980329350
"Moorman, A.C., Tong, X., Spradling, P.R., Rupp, L.B., Gordon, S.C., Lu, M., Teshale, E.H., Boscarino, J.A., Trinacty, C.M., Schmidt, M.A., Xu, F., Holmberg, S.D.","Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS)",2016,"Digestive Diseases and Sciences","61","7",,"2087","2093",,1,10.1007/s10620-016-4199-x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84969850661&doi=10.1007%2fs10620-016-4199-x&partnerID=40&md5=db76408c33d95ceba8c5fa329679f3c4",Article,Scopus,2-s2.0-84969850661
"Lu, M., Li, J., Zhang, T., Rupp, L.B., Trudeau, S., Holmberg, S.D., Moorman, A.C., Spradling, P.R., Teshale, E.H., Xu, F., Boscarino, J.A., Schmidt, M.A., Vijayadeva, V., Gordon, S.C., Xing, J., Tong, C., Nerenz, D.R., Lu, M., Lamerato, L., Li, J., Rupp, L.B., Akkerman, N., Oja-Tebbe, N., Zhang, T., Daar, Z.S., Smith, R.E., Parker, J.V., Donald, J.L., Keast, E.M.","Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection",2016,"Clinical Gastroenterology and Hepatology","14","7",,"1044","1055",,5,10.1016/j.cgh.2016.01.009,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84971642394&doi=10.1016%2fj.cgh.2016.01.009&partnerID=40&md5=15416e6771fb4a0661a3c9e13f7c51a5",Article,Scopus,2-s2.0-84971642394
"Reau, N., Fried, M.W., Nelson, D.R., Brown, R.S., Everson, G.T., Gordon, S.C., Jacobson, I.M., Lim, J.K., Pockros, P.J., Reddy, K.R., Sherman, K.E.","HCV Council - critical appraisal of data: Recommendations for clinical practice in a rapidly evolving therapeutic landscape",2016,"Liver International","36","4",,"488","502",,2,10.1111/liv.12993,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947996563&doi=10.1111%2fliv.12993&partnerID=40&md5=ec5dab8bbaa16dfe9fc677d075239c6c",Article,Scopus,2-s2.0-84947996563
"Ray Kim, W., Berg, T., Asselah, T., Flisiak, R., Fung, S., Gordon, S.C., Janssen, H.L.A., Lampertico, P., Lau, D., Bornstein, J.D., Schall, R.E.A., Dinh, P., Yee, L.J., Martins, E.B., Lim, S.G., Loomba, R., Petersen, J., Buti, M., Marcellin, P.","Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients",2016,"Journal of Hepatology","64","4",,"773","780",,27,10.1016/j.jhep.2015.11.012,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957066037&doi=10.1016%2fj.jhep.2015.11.012&partnerID=40&md5=7451025698860ac3a8bc01895daae722",Article,Scopus,2-s2.0-84957066037
"Sulejmani, N., Jafri, S.-M., Gordon, S.C.","Pharmacodynamics and pharmacokinetics of elbasvir and grazoprevir in the treatment of hepatitis C",2016,"Expert Opinion on Drug Metabolism and Toxicology","12","3",,"353","361",,3,10.1517/17425255.2016.1148685,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959219398&doi=10.1517%2f17425255.2016.1148685&partnerID=40&md5=71adbeac552cf6d1af50d659732171e7",Review,Scopus,2-s2.0-84959219398
"Xu, F., Moorman, A.C., Tong, X., Gordon, S.C., Rupp, L.B., Lu, M., Teshale, E.H., Spradling, P.R., Boscarino, J.A., Trinacty, C.M., Schmidt, M.A., Holmberg, S.D.","All-cause mortality and progression risks to hepatic decompensation and hepatocellular carcinoma in patients infected with Hepatitis C virus",2016,"Clinical Infectious Diseases","62","3",,"289","297",,10,10.1093/cid/civ860,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962219691&doi=10.1093%2fcid%2fciv860&partnerID=40&md5=c7dfce963f5686796116fac46d4e18b7",Article,Scopus,2-s2.0-84962219691
"Sulkowski, M.S., Vargas, H.E., Di Bisceglie, A.M., Kuo, A., Reddy, K.R., Lim, J.K., Morelli, G., Darling, J.M., Feld, J.J., Brown, R.S., Frazier, L.M., Stewart, T.G., Fried, M.W., Nelson, D.R., Jacobson, I.M., Afdhal, N., Alam, I., Ben-Ari, Z., Bredfeldt, J., Brown, R.S., Chung, R.T., Darling, J., Harlan, W., Di Bisceglie, A.M., Dickson, R.C., Elbeshbeshy, H.A., Everson, G., Feld, J., Fenkel, J.M., Fried, M.W., Galati, J., Gordon, S.C., Hassan, M., Hawkins, T.N., Hinestrosa, F., Jacobson, I.M., Kerr, C.A., Kuo, A., Kwo, P.Y., Levitsky, J., Lim, J., Lok, A.S., Mailliard, M., Manns, M.P., Morelli, G., Muir, A.J., Nelson, D., O'Leary, J.G., Pearlman, B.L., Pockros, P., Ramani, A., Reau, N., Reddy, K.R., Schiff, E.R., Sherman, K.E., Shiffman, M.L., Smith, C., Spivey, J.R., Sterling, R.K., Sulkowski, M.S., Szabo, G., Terrault, N.A., Trautwein, C., Watts, K., Williams, A., Zeuzem, S.","Effectiveness of Simeprevir Plus Sofosbuvir, with or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection",2016,"Gastroenterology","150","2",,"419","429",,48,10.1053/j.gastro.2015.10.013,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959473168&doi=10.1053%2fj.gastro.2015.10.013&partnerID=40&md5=7cdb5132556b188be8d1d4cc30d81569",Article,Scopus,2-s2.0-84959473168
"Teshale, E.H., Xing, J., Moorman, A., Holmberg, S.D., Spradling, P.R., Gordon, S.C., Rupp, L.B., Lu, M., Boscarino, J.A., Trinacity, C.M., Schmidt, M.A., Xu, F.","Higher all-cause hospitalization among patients with chronic hepatitis C: The Chronic Hepatitis Cohort Study (CHeCS), 2006-2013",2016,"Journal of Viral Hepatitis",,,,"","",,,10.1111/jvh.12548,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84970028656&doi=10.1111%2fjvh.12548&partnerID=40&md5=308413d65b389530bd891658df469c76",Article in Press,Scopus,2-s2.0-84970028656
"Buti, M., Gordon, S.C., Zuckerman, E., Lawitz, E., Calleja, J.L., Hofer, H., Gilbert, C., Palcza, J., Howe, A.Y.M., Dinubile, M.J., Robertson, M.N., Wahl, J., Barr, E., Forns, X.","Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection after Failure of Pegylated Interferon and Ribavirin with an Earlier-Generation Protease Inhibitor: Final 24-Week Results from C-SALVAGE",2016,"Clinical Infectious Diseases","62","1",,"32","36",,33,10.1093/cid/civ722,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954341991&doi=10.1093%2fcid%2fciv722&partnerID=40&md5=1c0e56d957c8232d95bdb82c192e4f4a",Article,Scopus,2-s2.0-84954341991
"Foster, G.R., Afdhal, N., Roberts, S.K., Br, N., Gane, E.J., Pianko, S., Lawitz, E., Thompson, A., Shiffman, M.L., Cooper, C., Towner, W.J., Conway, B., Ruane, P., Bourlie, M., Asselah, T., Berg, T., Zeuzem, S., Rosenberg, W., Agarwal, K., Stedman, C.A.M., Mo, H., Dvory Sobol, H., Han, L., Wang, J., McNally, J., Osinusi, A., Brainard, D.M., McHutchison, J.G., Mazzotta, F., Tran, T.T., Gordon, S.C., Patel, K., Reau, N., Mangia, A., Sulkowski, M.","Sofosbuvir and velpatasvir for HCV Genotype 2 and 3 infection",2015,"New England Journal of Medicine","373","27",,"2608","2617",,187,10.1056/NEJMoa1512612,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84952909361&doi=10.1056%2fNEJMoa1512612&partnerID=40&md5=bb501022208b93e256d99fec2d68a7d9",Article,Scopus,2-s2.0-84952909361
"Allison, R.D., Tong, X., Moorman, A.C., Ly, K.N., Rupp, L., Xu, F., Gordon, S.C., Holmberg, S.D.","Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010",2015,"Journal of Hepatology","63","4",,"822","828",,27,10.1016/j.jhep.2015.04.021,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941940324&doi=10.1016%2fj.jhep.2015.04.021&partnerID=40&md5=505c3c20d9d970775794fd239674233d",Article,Scopus,2-s2.0-84941940324
"Forns, X., Gordon, S.C., Zuckerman, E., Lawitz, E., Calleja, J.L., Hofer, H., Gilbert, C., Palcza, J., Howe, A.Y.M., Dinubile, M.J., Robertson, M.N., Wahl, J., Barr, E., Buti, M.","Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent",2015,"Journal of Hepatology","63","3", 5646,"564","572",,63,10.1016/j.jhep.2015.04.009,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939254831&doi=10.1016%2fj.jhep.2015.04.009&partnerID=40&md5=ca5f0ed185549ec7a81ee4aabd6f07d2",Article,Scopus,2-s2.0-84939254831
"Gonzalez, H.C., Lamerato, L., Rogers, C.G., Gordon, S.C.","Chronic Hepatitis C Infection as a Risk Factor for Renal Cell Carcinoma",2015,"Digestive Diseases and Sciences","60","6",,"1820","1824",,7,10.1007/s10620-015-3521-3,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930380077&doi=10.1007%2fs10620-015-3521-3&partnerID=40&md5=cd0a012e9976a5893b9c519e6ccdd407",Article,Scopus,2-s2.0-84930380077
"Tran, T.T., Gordon, S.C., Fung, S., Dinh, P., Yee, L., Martins, E.B., Buti, M., Marcellin, P.","Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials",2015,"PLoS ONE","10","3", e0121632,"","",,2,10.1371/journal.pone.0121632,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84925434509&doi=10.1371%2fjournal.pone.0121632&partnerID=40&md5=fd65af4eaf3c7dc8d773b46fe35ff8ec",Article,Scopus,2-s2.0-84925434509
"Jafri, S.-M.R., Gordon, S.C.","The Consequences of Cirrhosis in America",2015,"Digestive Diseases and Sciences","60","2",,"283","284",,,10.1007/s10620-014-3425-7,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922076639&doi=10.1007%2fs10620-014-3425-7&partnerID=40&md5=fe044fbbda56582119440c94a11b5e6c",Editorial,Scopus,2-s2.0-84922076639
"Gordon, S.C.","Polycystic liver disease",2015,"Gastroenterology and Hepatology","11","8",,"542","544",,1,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941654566&partnerID=40&md5=f88347a230b24b58d8145a14efed4504",Note,Scopus,2-s2.0-84941654566
"Jafri, S.-M., Gordon, S.C.","The safety of daclatasvir for the treatment of hepatitis C",2015,"Expert Opinion on Drug Safety","14","11",,"1787","1797",,,10.1517/14740338.2015.1100603,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947437063&doi=10.1517%2f14740338.2015.1100603&partnerID=40&md5=34e570e4fd83dd67bc41dc8fd7bc141e",Review,Scopus,2-s2.0-84947437063
"Monaghan, K.G., Gonzalez, H.C., Levin, A.M., Abouljoud, M.S., Gordon, S.C.","Post-transplant course of hepatitis c after living donor liver transplantation in association with polymorphisms near IFNL3",2015,"Journal of Interferon and Cytokine Research","35","4",,"313","316",,,10.1089/jir.2014.0111,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926452415&doi=10.1089%2fjir.2014.0111&partnerID=40&md5=343c009bac2985b23e4d9910c8e3956a",Article,Scopus,2-s2.0-84926452415
"Younossi, Z.M., Park, H., Saab, S., Ahmed, A., Dieterich, D., Gordon, S.C.","Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection",2015,"Alimentary Pharmacology and Therapeutics","41","6",,"544","563",,51,10.1111/apt.13081,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922770382&doi=10.1111%2fapt.13081&partnerID=40&md5=4ad68994abff1f349c57719bee2656f6",Article,Scopus,2-s2.0-84922770382
"Henkle, E., Lu, M., Rupp, L.B., Boscarino, J.A., Vijayadeva, V., Schmidt, M.A., Gordon, S.C.","Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohort",2015,"Clinical Infectious Diseases","60","4",,"514","522",,2,10.1093/cid/ciu879,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922353668&doi=10.1093%2fcid%2fciu879&partnerID=40&md5=83419def56ac013df461803c28a11239",Article,Scopus,2-s2.0-84922353668
"Stravitz, R.T., Reuben, A., Mizrahi, M., Lalazar, G., Brown, K., Gordon, S.C., Ilan, Y., Sanyal, A.","Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation",2015,"Journal of Hepatology","63","6",,"1345","1351",,2,10.1016/j.jhep.2015.07.021,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84951569534&doi=10.1016%2fj.jhep.2015.07.021&partnerID=40&md5=50fe3045642c4559b1a6d10a1e57979d",Article,Scopus,2-s2.0-84951569534
"Boscarino, J.A., Lu, M., Moorman, A.C., Gordon, S.C., Rupp, L.B., Spradling, P.R., Teshale, E.H., Schmidt, M.A., Vijayadeva, V., Holmberg, S.D.","Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: The Chronic Hepatitis Cohort Study (CHeCS)",2015,"Hepatology","61","3",,"802","811",,17,10.1002/hep.27422,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923293017&doi=10.1002%2fhep.27422&partnerID=40&md5=0b47f695108a45af0a99651a913afd6d",Article,Scopus,2-s2.0-84923293017
"Gordon, S.C., Lamerato, L.E., Rupp, L.B., Holmberg, S.D., Moorman, A.C., Spradling, P.R., Teshale, E., Xu, F., Boscarino, J.A., Vijayadeva, V., Schmidt, M.A., Oja-Tebbe, N., Lu, M.","Prevalence of cirrhosis in hepatitis c patients in the chronic hepatitis cohort study (CHeCS): A retrospective and prospective observational study",2015,"American Journal of Gastroenterology","110","8",,"1169","1177",,9,10.1038/ajg.2015.203,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84939262714&doi=10.1038%2fajg.2015.203&partnerID=40&md5=768aaa6dd8e44cde5da19175e7366ce3",Article,Scopus,2-s2.0-84939262714
"Alqahtani, S.A., Afdhal, N., Zeuzem, S., Gordon, S.C., Mangia, A., Kwo, P., Fried, M., Yang, J.C., Ding, X., Pang, P.S., Mchutchison, J.G., Pound, D., Reddy, K.R., Marcellin, P., Kowdley, K.V., Sulkowski, M.","Safety and Tolerability Of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Phase III ION Trials",2015,"Hepatology","62","1",,"25","30",,35,10.1002/hep.27890,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84933181408&doi=10.1002%2fhep.27890&partnerID=40&md5=4af32a58d79cddfa31cc36a4bf47c716",Article,Scopus,2-s2.0-84933181408
"Afdhal, N.H., Bacon, B.R., Patel, K., Lawitz, E.J., Gordon, S.C., Nelson, D.R., Challies, T.L., Nasser, I., Garg, J., Wei, L.-J., McHutchison, J.G.","Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: A united states multicenter study",2015,"Clinical Gastroenterology and Hepatology","13","4",,"772","779.e3",,28,10.1016/j.cgh.2014.12.014,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84925004901&doi=10.1016%2fj.cgh.2014.12.014&partnerID=40&md5=9fc799bc8915b12580e81b1a903c2a9d",Article,Scopus,2-s2.0-84925004901
"Gordon, S.C., Muir, A.J., Lim, J.K., Pearlman, B., Argo, C.K., Ramani, A., Maliakkal, B., Alam, I., Stewart, T.G., Vainorius, M., Peter, J., Nelson, D.R., Fried, M.W., Reddy, K.R.","Safety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGET",2015,"Journal of Hepatology","62","2",,"286","293",,47,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922268018&partnerID=40&md5=2cad0a8283eb1f30326eb9ea53fbbef9",Article,Scopus,2-s2.0-84922268018
"Gane, E.J., Lim, Y.-S., Gordon, S.C., Visvanathan, K., Sicard, E., Fedorak, R.N., Roberts, S., Massetto, B., Ye, Z., Pflanz, S., Garrison, K.L., Gaggar, A., Subramanian, G.M., McHutchison, J.G., Kottilil, S., Freilich, B., Coffin, C.S., Cheng, W., Kim, Y.J.","The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection",2015,"Journal of Hepatology","63","2",,"320","328",,61,10.1016/j.jhep.2015.02.037,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84935451137&doi=10.1016%2fj.jhep.2015.02.037&partnerID=40&md5=7f916fdf04102fd37ad9098ff7482c28",Article,Scopus,2-s2.0-84935451137
"Fung, S., Gordon, S.C., Krastev, Z., Horban, A., Petersen, J., Sperl, J., Gane, E., Jacobson, I.M., Yee, L.J., Dinh, P., Martins, E.B., Flaherty, J.F., Kitrinos, K.M., Dusheiko, G., Trinh, H., Flisiak, R., Rustgi, V.K., Buti, M., Marcellin, P.","Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log&lt;inf&gt;10&lt;/inf&gt; copies/ml)",2015,"Liver International","35","2",,"422","428",,2,10.1111/liv.12694,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921485509&doi=10.1111%2fliv.12694&partnerID=40&md5=ea7ad1c4d3668fd58562120d9aa7c62e",Article,Scopus,2-s2.0-84921485509
"Hirschfield, G.M., Mason, A., Luketic, V., Lindor, K., Gordon, S.C., Mayo, M., Kowdley, K.V., Vincent, C., Bodhenheimer, H.C., Parés, A., Trauner, M., Marschall, H.-U., Adorini, L., Sciacca, C., Beecher-Jones, T., Castelloe, E., Böhm, O., Shapiro, D.","Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid",2015,"Gastroenterology","148","4",,"751","761.e8",,136,10.1053/j.gastro.2014.12.005,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84925362562&doi=10.1053%2fj.gastro.2014.12.005&partnerID=40&md5=676043b1327097b9f3f2de8ecb768aeb",Article,Scopus,2-s2.0-84925362562
"Moorman, A.C., Xing, J., Ko, S., Rupp, L.B., Xu, F., Gordon, S.C., Lu, M., Spradling, P.R., Teshale, E.H., Boscarino, J.A., Vijayadeva, V., Schmidt, M.A., Holmberg, S.D., Xing, J., Tong, C., Nerenz, D.R., Lamerato, L., Wang, Y., Akkerman, N., Oja-Tebbe, N., Zhang, T., Sitarik, A., Larkin, D., Daar, Z.S., Curry, P.J., Smith, R.E., Parker, J.V., Donald, J.L., Keast, E.M.","Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention",2015,"Hepatology","61","5",,"1479","1484",,9,10.1002/hep.27365,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928213649&doi=10.1002%2fhep.27365&partnerID=40&md5=df2cfb7500fc17ff99c3a5d782266cd8",Article,Scopus,2-s2.0-84928213649
"Spradling, P.R., Tong, X., Rupp, L.B., Moorman, A.C., Lu, M., Teshale, E.H., Gordon, S.C., Vijayadeva, V., Boscarino, J.A., Schmidt, M.A., Holmberg, S.D., Nerenz, D.R., Lamerato, L., Akkerman, N., Oja-Tebbe, N., Cogan, C.M., Larkin, D., Daar, Z.S., Leader, J.B., Smith, R.E., Sylva, K.E., Parker, J.V., Schmidt, M.M., Donald, J.L., Keast, E.M.","Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010",2014,"Clinical Infectious Diseases","59","7",,"976","981",,10,10.1093/cid/ciu509,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926463417&doi=10.1093%2fcid%2fciu509&partnerID=40&md5=7f3267565b083d55cb83e3ecc71ae323",Article,Scopus,2-s2.0-84926463417
"Mahajan, R., Xing, J., Liu, S.J., Ly, K.N., Moorman, A.C., Rupp, L., Xu, F., Holmberg, S.D., Teshale, E.H., Spradling, P.R., Gordon, S.C., Nerenz, D.R., Lu, M., Lamerato, L., Rupp, L.B., Akkerman, N., Oja-Tebbe, N., Cogan, C.M., Larkin, D., Boscarino, J.A., Daar, Z.S., Leader, J.B., Smith, R.E., Nakasato, C.C., Vijayadeva, V., Sylva, K.E., Parker, J.V., Schmidt, M.M., Schmidt, M.A., Donald, J.L., Keast, E.M.","Mortality among persons in care with hepatitis c virus infection: The chronic hepatitis cohort study (CHeCS), 2006-2010",2014,"Clinical Infectious Diseases","58","8",,"1055","1061",,37,10.1093/cid/ciu077,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897465495&doi=10.1093%2fcid%2fciu077&partnerID=40&md5=2105f41840b5fe6db135abddeb981ec0",Article,Scopus,2-s2.0-84897465495
"Younossi, Z.M., Kanwal, F., Saab, S., Brown, K.A., El-Serag, H.B., Kim, W.R., Ahmed, A., Kugelmas, M., Gordon, S.C.","The impact of hepatitis C burden: An evidence-based approach",2014,"Alimentary Pharmacology and Therapeutics","39","5",,"518","531",,59,10.1111/apt.12625,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893810524&doi=10.1111%2fapt.12625&partnerID=40&md5=6f252f743030b6305f1f7ab43d03d979",Article,Scopus,2-s2.0-84893810524
"Gordon, S.C., Martins, E.B., Yee, L.J.","Reply",2014,"Hepatology","59","6",,"2427","",,,10.1002/hep.26902,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901632685&doi=10.1002%2fhep.26902&partnerID=40&md5=b5875948da38f4a5b9f839c6984d00d6",Letter,Scopus,2-s2.0-84901632685
"Saab, S., Gordon, S.C., Park, H., Sulkowski, M., Ahmed, A., Younossi, Z.","Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection",2014,"Alimentary Pharmacology and Therapeutics","40","6",,"657","675",,43,10.1111/apt.12871,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906218627&doi=10.1111%2fapt.12871&partnerID=40&md5=707e0eaaa3875ae55bbf5400b2f3e480",Article,Scopus,2-s2.0-84906218627
"Tang, J., Sharma, R., Lamerato, L., Sheehan, M., Krajenta, R., Gordon, S.C.","Is previous exposure to hepatitis B a risk factor for pancreatic cancer or hepatocellular carcinoma?",2014,"Journal of Clinical Gastroenterology","48","8",,"729","733",,6,10.1097/MCG.0000000000000111,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905992236&doi=10.1097%2fMCG.0000000000000111&partnerID=40&md5=d11e648a36e3422ae788699168ddebd9",Article,Scopus,2-s2.0-84905992236
"Boscarino, J.A., Sitarik, A., Gordon, S.C., Rupp, L.B., Nerenz, D.R., Vijayadeva, V., Schmidt, M.A., Henkle, E., Lu, M.","Risk Factors for Hepatitis C Infection Among Vietnam Era Veterans Versus Nonveterans: Results from the Chronic Hepatitis Cohort Study (CHeCS)",2014,"Journal of Community Health","39","5",,"914","921",,2,10.1007/s10900-014-9863-5,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84918777482&doi=10.1007%2fs10900-014-9863-5&partnerID=40&md5=faf3e47ad9e2ed7c046a4af65ea1accb",Article,Scopus,2-s2.0-84918777482
"Li, J., Gordon, S.C., Rupp, L.B., Zhang, T., Boscarino, J.A., Vijayadeva, V., Schmidt, M.A., Lu, M.","The validity of serum markers for fibrosis staging in chronic hepatitis B and C",2014,"Journal of Viral Hepatitis","21","12",,"930","937",,33,10.1111/jvh.12224,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84911427152&doi=10.1111%2fjvh.12224&partnerID=40&md5=1f3d2a095ec9cb2aaf3b6654b4cb3c43",Article,Scopus,2-s2.0-84911427152
"Teshale, E., Lu, M., Rupp, L.B., Holmberg, S.D., Moorman, A.C., Spradling, P., Vijayadeva, V., Boscarino, J.A., Schmidt, M.A., Gordon, S.C.","APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: The Chronic Hepatitis Cohort Study (CHeCS)",2014,"Journal of Viral Hepatitis","21","12",,"917","920",,28,10.1111/jvh.12279,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84911417990&doi=10.1111%2fjvh.12279&partnerID=40&md5=2deec0aa8f00942edcaea0f7ae09a227",Article,Scopus,2-s2.0-84911417990
"Vijayadeva, V., Spradling, P.R., Moorman, A.C., Rupp, L.B., Lu, M., Gordon, S.C., Henkle, E., Boscarino, J.A., Teshale, E.H., Nakasato, C.","Hepatitis B virus infection testing and prevalence among Asian and Pacific Islanders",2014,"American Journal of Managed Care","20","4",,"e98","e104",,5,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903388808&partnerID=40&md5=49080329ff588371eb5a55928b153cb6",Article,Scopus,2-s2.0-84903388808
"Lu, M., Rupp, L.B., Moorman, A.C., Li, J., Zhang, T., Lamerato, L.E., Holmberg, S.D., Spradling, P.R., Teshale, E.H., Vijayadeva, V., Boscarino, J.A., Schmidt, M.A., Nerenz, D.R., Gordon, S.C.","Comparative Effectiveness Research of Chronic Hepatitis B and C Cohort Study (CHeCS): Improving Data Collection and Cohort Identification",2014,"Digestive Diseases and Sciences","59","12",,"3053","3061",,2,10.1007/s10620-014-3272-6,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84912532552&doi=10.1007%2fs10620-014-3272-6&partnerID=40&md5=e028ebe6ab87db1cb18be3bf0c01a5e6",Article,Scopus,2-s2.0-84912532552
"Gordon, S.C., Reddy, K.R., Jacobson, I.M., Poordad, F., Bronowicki, J.-P., Bacon, B., Buti, M., Hu, K.-Q., Pedicone, L.D., Burroughs, M., Brass, C.A., Albrecht, J.K., Lawitz, E.J.","Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis c genotype 1: Impact of baseline viral load on sustained virologic response",2014,"Journal of Clinical Gastroenterology","48","5",,"435","443",,2,10.1097/MCG.0000000000000000,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84898599027&doi=10.1097%2fMCG.0000000000000000&partnerID=40&md5=0433a0ed0586b49964c0daffb503f483",Article,Scopus,2-s2.0-84898599027
"Kowdley, K.V., Gordon, S.C., Reddy, K.R., Rossaro, L., Bernstein, D.E., Lawitz, E., Shiffman, M.L., Schiff, E., Ghalib, R., Ryan, M., Rustgi, V., Chojkier, M., Herring, R., Di Bisceglie, A.M., Pockros, P.J., Subramanian, G.M., An, D., Svarovskaia, E., Hyland, R.H., Pang, P.S., Symonds, W.T., McHutchison, J.G., Muir, A.J., Pound, D., Fried, M.W.","Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis",2014,"New England Journal of Medicine","370","20",,"1879","1888",,581,10.1056/NEJMoa1402355,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84900326091&doi=10.1056%2fNEJMoa1402355&partnerID=40&md5=556de055e05609f1cf39af4c235acabd",Article,Scopus,2-s2.0-84900326091
"Afdhal, N., Reddy, K.R., Nelson, D.R., Lawitz, E., Gordon, S.C., Schiff, E., Nahass, R., Ghalib, R., Gitlin, N., Herring, R., Lalezari, J., Younes, Z.H., Pockros, P.J., Di Bisceglie, A.M., Arora, S., Subramanian, G.M., Zhu, Y., Dvory-Sobol, H., Yang, J.C., Pang, P.S., Symonds, W.T., McHutchison, J.G., Muir, A.J., Sulkowski, M., Kwo, P.","Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection",2014,"New England Journal of Medicine","370","16",,"1483","1493",,734,10.1056/NEJMoa1316366,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84898669547&doi=10.1056%2fNEJMoa1316366&partnerID=40&md5=08ebd74147c5428ff200d6d653338617",Article,Scopus,2-s2.0-84898669547
"Selmi, C., Cavaciocchi, F., Lleo, A., Cheroni, C., De Francesco, R., Lombardi, S.A., De Santis, M., Meda, F., Raimondo, M.G., Crotti, C., Folci, M., Zammataro, L., Mayo, M.J., Bach, N., Shimoda, S., Gordon, S.C., Miozzo, M., Invernizzi, P., Podda, M., Scavelli, R., Martin, M.R., LaSalle, J.M., Gershwin, M.E.","Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis",2014,"Frontiers in Immunology","5","MAR", Article 128,"","",,16,10.3389/fimmu.2014.00128,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897930527&doi=10.3389%2ffimmu.2014.00128&partnerID=40&md5=ba1f2d3bb1b6cca2e719d554200d06ae",Article,Scopus,2-s2.0-84897930527
"Vierling, J.M., Davis, M., Flamm, S., Gordon, S.C., Lawitz, E., Yoshida, E.M., Galati, J., Luketic, V., McCone, J., Jacobson, I., Marcellin, P., Muir, A.J., Poordad, F., Pedicone, L.D., Albrecht, J., Brass, C., Howe, A.Y.M., Colvard, L.Y., Helmond, F.A., Deng, W., Treitel, M., Wahl, J., Bronowicki, J.-P.","Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response",2014,"Journal of Hepatology","60","4",,"748","756",,32,10.1016/j.jhep.2013.12.013,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896400773&doi=10.1016%2fj.jhep.2013.12.013&partnerID=40&md5=d19df6ff7095f354f55b4065c4551fdb",Article,Scopus,2-s2.0-84896400773
"Manns, M., Pol, S., Jacobson, I.M., Marcellin, P., Gordon, S.C., Peng, C.-Y., Chang, T.-T., Everson, G.T., Heo, J., Gerken, G., Yoffe, B., Towner, W.J., Bourliere, M., Metivier, S., Chu, C.-J., Sievert, W., Bronowicki, J.-P., Thabut, D., Lee, Y.-J., Kao, J.-H., McPhee, F., Kopit, J., Mendez, P., Linaberry, M., Hughes, E., Noviello, S.","All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study",2014,"The Lancet","384","9954",,"1597","1605",,188,10.1016/S0140-6736(14)61059-X,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906814530&doi=10.1016%2fS0140-6736%2814%2961059-X&partnerID=40&md5=ed8fd591f315a6d8b64d91e839ead2ad",Article,Scopus,2-s2.0-84906814530
"Selmi, C., Cavaciocchi, F., Lleo, A., Cheroni, C., de Francesco, R., Lombardi, S.A., de Santis, M., Meda, F., Raimondo, M.G., Crotti, C., Folci, M., Zammataro, L., Mayo, M.J., Bach, N., Shimoda, S., Gordon, S.C., Miozzo, M., Invernizzi, P., Podda, M., Scavelli, R., Martin, M.R., Seldin, M.F., LaSalle, J.M., Gershwin, M.E.","Corrigendum: Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis",2014,"Frontiers in Immunology","5","AUG", Article 371,"","",,2,10.3389/fimmu.2014.00371,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940362534&doi=10.3389%2ffimmu.2014.00371&partnerID=40&md5=cc947f4e139d827a80dd60da7763c755",Note,Scopus,2-s2.0-84940362534
"Muir, A.J., Arora, S., Everson, G., Flisiak, R., George, J., Ghalib, R., Gordon, S.C., Gray, T., Greenbloom, S., Hassanein, T., Hillson, J., Horga, M.A., Jacobson, I.M., Jeffers, L., Kowdley, K.V., Lawitz, E., Lueth, S., Rodriguez-Torres, M., Rustgi, V., Shemanski, L., Shiffman, M.L., Srinivasan, S., Vargas, H.E., Vierling, J.M., Xu, D., Lopez-Talavera, J.C., Zeuzem, S.","A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection",2014,"Journal of Hepatology","61","6",,"1238","1246",,35,10.1016/j.jhep.2014.07.022,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922813934&doi=10.1016%2fj.jhep.2014.07.022&partnerID=40&md5=b89b32529285022aca89866a617cdb4d",Article,Scopus,2-s2.0-84922813934
"Gerbi, G.B., Rupp, L.B., Ko, S.C., Moorman, A.C., Holmberg, S.D., Xu, F., Teshale, E.H., Spradling, P.R., Gordon, S.C., Nerenz, D.R., Lu, M., Lamerato, L., Akkerman, N., Oja-Tebbe, N.J., Cogan, C.M., Larkin, D., Boscarino, J.A., Daar, Z.S., Smith, R.E., Curry, P.J., Geise, B.D., Leader, J.B., Nakasato, C.C., Vijayadeva, V., Sylva, K.E., Parker, J.V., Schmidt, M.M., Henkle, E.M., Dodge, T.L., Keast, E.M., Drew, L.","Reported reasons for testing among hepatitis B virus-infected patients - Chronic Hepatitis Cohort Study (CHeCS), United States, 2006-2010",2014,"Liver International","34","6",,"e162","e163",,2,10.1111/liv.12509,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902540049&doi=10.1111%2fliv.12509&partnerID=40&md5=1dd79e5196e78f753ca6ca34504c7bbe",Letter,Scopus,2-s2.0-84902540049
"Gordon, S.C., Lamerato, L.E., Rupp, L.B., Li, J., Holmberg, S.D., Moorman, A.C., Spradling, P.R., Teshale, E.H., Vijayadeva, V., Boscarino, J.A., Henkle, E.M., Oja-Tebbe, N., Lu, M., Nerenz, D., Akkerman, N., Cogan, C., Zhang, T., Larkin, D., Daar, Z., Leader, J., Curry, P., Smith, R., Vijayadeva, V.X., Nakasato, C., Sylva, K., Parker, J., Schmidt, M.M., Schmidt, M.A., Dodge, T., Donald, J., Keast, E.","Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population",2014,"Clinical Gastroenterology and Hepatology","12","5",,"885","893",,68,10.1016/j.cgh.2013.09.062,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899085087&doi=10.1016%2fj.cgh.2013.09.062&partnerID=40&md5=b9a67584c51579441bd248d6743ff410",Article,Scopus,2-s2.0-84899085087
"Hepatitis C Task Force, Boldt, M.D., Brill, J.V., Davis, G.L., Gordon, S.C., Kim, A.Y., Kosinski, L.R., Levy, A.G., Nahass, R.G., Allen, J.I.","Hepatitis C screening: summary of recommendations from the clinical decision tool.",2013,"Gastroenterology","145","5",,"1146","1149",,3,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84894331714&partnerID=40&md5=51fac7d4e099be0629eebd4d7f87b6d2",Article,Scopus,2-s2.0-84894331714
"Jazwinski, A.B., Clark, P.J., Thompson, A.J., Gordon, S.C., Lawitz, E.J., Noviello, S., Brass, C.A., Pedicone, L.D., Albrecht, J.K., Sulkowski, M.S., Muir, A.J.","Predictors of consent to pharmacogenomics testing in the IDEAL study",2013,"Pharmacogenetics and Genomics","23","11",,"619","623",,,10.1097/FPC.0000000000000002,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84886587836&doi=10.1097%2fFPC.0000000000000002&partnerID=40&md5=fe27028170ec5e06268706927888d4e9",Article,Scopus,2-s2.0-84886587836
"Gordon, S.C., Hamzeh, F.M., Pockros, P.J., Hoop, R.S., Buikema, A.R., Korner, E.J., Terrault, N.A.","Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease",2013,"Alimentary Pharmacology and Therapeutics","38","7",,"784","793",,11,10.1111/apt.12454,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883488333&doi=10.1111%2fapt.12454&partnerID=40&md5=d56cfe27738ef02a44da86ef268b3507",Article,Scopus,2-s2.0-84883488333
"Lawitz, E., Sulkowski, M., Jacobson, I., Kraft, W.K., Maliakkal, B., Al-Ibrahim, M., Gordon, S.C., Kwo, P., Rockstroh, J.K., Panorchan, P., Miller, M., Caro, L., Barnard, R., Hwang, P.M., Gress, J., Quirk, E., Mobashery, N.","Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics",2013,"Antiviral Research","99","3",,"214","220",,18,10.1016/j.antiviral.2013.05.015,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884550531&doi=10.1016%2fj.antiviral.2013.05.015&partnerID=40&md5=947caaebe7462da16fd46078a1729105",Article,Scopus,2-s2.0-84884550531
"Barnard, R.J.O., Howe, J.A., Ogert, R.A., Zeuzem, S., Poordad, F., Gordon, S.C., Ralston, R., Tong, X., Sniukiene, V., Strizki, J., Ryan, D., Long, J., Qiu, P., Brass, C.A., Albrecht, J., Burroughs, M., Vuocolo, S., Hazuda, D.J.","Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies",2013,"Virology","444","1-2",,"329","336",,47,10.1016/j.virol.2013.06.029,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84882876118&doi=10.1016%2fj.virol.2013.06.029&partnerID=40&md5=cd833df48bb3f729b0279a2dddf2e5cf",Article,Scopus,2-s2.0-84882876118
"Mahajan, R., Moorman, A.C., Liu, S.J., Rupp, L., Klevens, R.M., Holmberg, S.D., Teshale, E.H., Spradling, P.R., Moorman, A.C., Gordon, S.C., Nerenz, D.R., Lu, M., Lamerato, L., Rupp, L.B., Akkerman, N., Oja-Tebbe, N., Cogan, C.M., Larkin, D., Boscarino, J.A., Daar, Z.S., Leader, J.B., Smith, R.E., Nakasato, C.C., Vijayadeva, V., Sylva, K.E., Parker, J.V., Schmidt, M.M., Henkle, E.M., Dodge, T.L., Keast, E.M.","Use of the international classification of diseases, 9th revision, coding in identifying chronic hepatitis B virus infection in health system data: Implications for national surveillance",2013,"Journal of the American Medical Informatics Association","20","3",,"441","445",,3,10.1136/amiajnl-2012-001558,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879925918&doi=10.1136%2famiajnl-2012-001558&partnerID=40&md5=a1f9fe7780ce82824e774a05626a5c96",Article,Scopus,2-s2.0-84879925918
"Gordon, S.C., Krastev, Z., Horban, A., Petersen, J., Sperl, J., Dinh, P., Martins, E.B., Yee, L.J., Flaherty, J.F., Kitrinos, K.M., Rustgi, V.K., Marcellin, P.","Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load",2013,"Hepatology","58","2",,"505","513",,56,10.1002/hep.26277,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881030204&doi=10.1002%2fhep.26277&partnerID=40&md5=e1e5f9ef9a61f1006b494e2180a87ab8",Article,Scopus,2-s2.0-84881030204
"Manns, M.P., Pockros, P.J., Norkrans, G., Smith, C.I., Morgan, T.R., Häussinger, D., Shiffman, M.L., Hadziyannis, S.J., Schmidt, W.N., Jacobson, I.M., Bárcena, R., Schiff, E.R., Shaikh, O.S., Bacon, B., Marcellin, P., Deng, W., Esteban-Mur, R., Poynard, T., Pedicone, L.D., Brass, C.A., Albrecht, J.K., Gordon, S.C.","Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin",2013,"Journal of Viral Hepatitis","20","8",,"524","529",,43,10.1111/jvh.12074,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879795584&doi=10.1111%2fjvh.12074&partnerID=40&md5=4c10016accae3679010b6f37da4b6f69",Article,Scopus,2-s2.0-84879795584
"Holmberg, S.D., Lu, M., Rupp, L.B., Lamerato, L.E., Moorman, A.C., Vijayadeva, V., Boscarino, J.A., Henkle, E.M., Gordon, S.C.","Noninvasive Serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort",2013,"Clinical Infectious Diseases","57","2",,"240","246",,54,10.1093/cid/cit245,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879652821&doi=10.1093%2fcid%2fcit245&partnerID=40&md5=3bd097ba283c3cab8a3aaa6141cde5b6",Article,Scopus,2-s2.0-84879652821
"Gordon, S.C., Yoshida, E.M., Lawitz, E.J., Bacon, B.R., Sulkowski, M.S., Davis, M., Poordad, F., Bronowicki, J.-P., Esteban, R., Sniukiene, V., Burroughs, M.H., Deng, W., Dutko, F.J., Brass, C.A., Albrecht, J.K., Rajender Reddy, K.","Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin",2013,"Alimentary Pharmacology and Therapeutics","38","1",,"16","27",,17,10.1111/apt.12342,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878799939&doi=10.1111%2fapt.12342&partnerID=40&md5=e2352917929ccbe1ae29f0f1ab301f1f",Article,Scopus,2-s2.0-84878799939
"Lawitz, E.J., Hill, J.M., Marbury, T., DeMicco, M.P., Delaney, W., Yang, J., Moorehead, L., Mathias, A., Mo, H., McHutchison, J.G., Rodriguez-Torres, M., Gordon, S.C.","A Phase I, randomized, placebo-controlled, 3-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patients",2013,"Antiviral Therapy","18","3",,"311","319",,7,10.3851/IMP2415,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878102031&doi=10.3851%2fIMP2415&partnerID=40&md5=6e20f0d53c9ebde0075bfe8cd2de0e7d",Article,Scopus,2-s2.0-84878102031
"Ogert, R.A., Howe, J.A., Vierling, J.M., Kwo, P.Y., Lawitz, E.J., McCone, J., Schiff, E.R., Pound, D., Davis, M.N., Gordon, S.C., Ravendhran, N., Rossaro, L., Jacobson, I.M., Ralston, R., Chaudhri, E., Qiu, P., Pedicone, L.D., Brass, C.A., Albrecht, J.K., Barnard, R.J.O., Hazuda, D.J., Howe, A.Y.M.","Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial",2013,"Antiviral Therapy","18","3",,"387","397",,14,10.3851/IMP2549,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878036817&doi=10.3851%2fIMP2549&partnerID=40&md5=00bb2e9c1a53efd9fdd70108b26739ef",Article,Scopus,2-s2.0-84878036817
"Lawitz, E., Mangia, A., Wyles, D., Rodriguez-Torres, M., Hassanein, T., Gordon, S.C., Schultz, M., Davis, M.N., Kayali, Z., Reddy, K.R., Jacobson, I.M., Kowdley, K.V., Nyberg, L., Subramanian, G.M., Hyland, R.H., Arterburn, S., Jiang, D., McNally, J., Brainard, D., Symonds, W.T., McHutchison, J.G., Sheikh, A.M., Younossi, Z., Gane, E.J.","Sofosbuvir for previously untreated chronic hepatitis C infection",2013,"New England Journal of Medicine","368","20",,"1878","1887",,1002,10.1056/NEJMoa1214853,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877730954&doi=10.1056%2fNEJMoa1214853&partnerID=40&md5=1ef15b118513d4d0146212ba580528e0",Article,Scopus,2-s2.0-84877730954
"Jacobson, I.M., Gordon, S.C., Kowdley, K.V., Yoshida, E.M., Rodriguez-Torres, M., Sulkowski, M.S., Shiffman, M.L., Lawitz, E., Everson, G., Bennett, M., Schiff, E., Al-Assi, M.T., Subramanian, G.M., An, D., Lin, M., McNally, J., Brainard, D., Symonds, W.T., McHutchison, J.G., Patel, K., Feld, J., Pianko, S., Nelson, D.R.","Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options",2013,"New England Journal of Medicine","368","20",,"1867","1877",,676,10.1056/NEJMoa1214854,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877739274&doi=10.1056%2fNEJMoa1214854&partnerID=40&md5=26973387dc54402f3cf776674e7f04b4",Article,Scopus,2-s2.0-84877739274
"Eckman, M.H., Talal, A.H., Gordon, S.C., Schiff, E., Sherman, K.E.","Cost-effectiveness of screening for chronic hepatitis C infection in the United States",2013,"Clinical Infectious Diseases","56","10",,"1382","1393",,23,10.1093/cid/cit069,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877261106&doi=10.1093%2fcid%2fcit069&partnerID=40&md5=15e8f4b9fd58a0ca16ca570685ca3096",Article,Scopus,2-s2.0-84877261106
"Kowdley, K.V., Lawitz, E., Crespo, I., Hassanein, T., Davis, M.N., Demicco, M., Bernstein, D.E., Afdhal, N., Vierling, J.M., Gordon, S.C., Anderson, J.K., Hyland, R.H., Dvory-Sobol, H., An, D., Hindes, R.G., Albanis, E., Symonds, W.T., Michelle Berrey, M., Nelson, D.R., Jacobson, I.M.","Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): An open-label, randomised, multicentre phase 2 trial",2013,"The Lancet","381","9883",,"2100","2107",,182,10.1016/S0140-6736(13)60247-0,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878976866&doi=10.1016%2fS0140-6736%2813%2960247-0&partnerID=40&md5=9dcc427cd5926411568dbf2bce801bde",Article,Scopus,2-s2.0-84878976866
"Boscarino, J.A., Gordon, S.C., Rupp, L.B., Schmidt, M.A., Vijayadeva, V., Moorman, A., Xu, F., Holmberg, S.D., Ko, S.C.","Locations and reasons for initial testing for hepatitis C infection - Chronic Hepatitis Cohort Study, United States, 2006-2010",2013,"Morbidity and Mortality Weekly Report","62","32",,"645","648",,6,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881625722&partnerID=40&md5=462205cc297f0f74611564c1fb38f3ed",Article,Scopus,2-s2.0-84881625722
"Gonzalez, H.C., Jafri, S.M., Gordon, S.C.","Role of liver biopsy in the era of direct-acting antivirals.",2013,"Current gastroenterology reports","15","2",,"307","",,10,10.1007/s11894-012-0307-z,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878797763&doi=10.1007%2fs11894-012-0307-z&partnerID=40&md5=85ff6f2656b8564187d97e0954b5bfde",Review,Scopus,2-s2.0-84878797763
"Gonzalez, H.C., Jafri, S.M., Gordon, S.C.","Role of liver biopsy in the era of direct-acting antivirals",2013,"Current Gastroenterology Reports","15","2", 307,"","",,2,10.1007/s11894-012-0307-z,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872073834&doi=10.1007%2fs11894-012-0307-z&partnerID=40&md5=ed082bc5b0fe64be111aa500f82845c5",Article,Scopus,2-s2.0-84872073834
"Baxa, D.M., Thekdi, A.D., Golembieski, A., Krishnan, P.V., Sharif, O., Kizy, A., Shetron-Rama, L., Jovanovich, J., Chappell, B.J., Snow-Lampart, A., Borroto-Esoda, K., Gordon, S.C.","Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States",2013,"Journal of Hepatology","58","2",,"212","216",,21,10.1016/j.jhep.2012.09.014,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872419777&doi=10.1016%2fj.jhep.2012.09.014&partnerID=40&md5=14fcdd440dd42f6d16275ef52a131935",Article,Scopus,2-s2.0-84872419777
"Sharif, O., Krishnan, P.V., Thekdi, A.D., Gordon, S.C.","Acute hepatitis b in an urban tertiary care hospital in the united states: A cohort evaluation",2013,"Journal of Clinical Gastroenterology","47","9",,"e87","e90",,3,10.1097/MCG.0b013e31828a383c,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884671704&doi=10.1097%2fMCG.0b013e31828a383c&partnerID=40&md5=e04a2f7d5931ad0f96a3122279bd9ace",Article,Scopus,2-s2.0-84884671704
"Moorman, A.C., Gordon, S.C., Rupp, L.B., Spradling, P.R., Teshale, E.H., Lu, M., Nerenz, D.R., Nakasato, C.C., Boscarino, J.A., Henkle, E.M., Oja-Tebbe, N.J., Xing, J., Ward, J.W., Holmberg, S.D.","Baseline characteristics and mortality among people in care for chronic viral hepatitis: The chronic hepatitis cohort study",2013,"Clinical Infectious Diseases","56","1",,"40","50",,75,10.1093/cid/cis815,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871245811&doi=10.1093%2fcid%2fcis815&partnerID=40&md5=b8b9e564427c8f5aa0019bbdb10187c7",Article,Scopus,2-s2.0-84871245811
"Jafri, S.-M., Gordon, S.C.","Care of the Cirrhotic Patient",2012,"Infectious Disease Clinics of North America","26","4",,"980","994",,3,10.1016/j.idc.2012.08.009,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867692171&doi=10.1016%2fj.idc.2012.08.009&partnerID=40&md5=9c221abbaca485f36b6343649c7ed716",Review,Scopus,2-s2.0-84867692171
"Gordon, S.C., Pockros, P.J., Terrault, N.A., Hoop, R.S., Buikema, A., Nerenz, D., Hamzeh, F.M.","Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection",2012,"Hepatology","56","5",,"1651","1660",,56,10.1002/hep.25842,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868212975&doi=10.1002%2fhep.25842&partnerID=40&md5=e811392c123750de1f776a2a7aadce16",Article,Scopus,2-s2.0-84868212975
"Spradling, P.R., Rupp, L., Moorman, A.C., Lu, M., Teshale, E.H., Gordon, S.C., Nakasato, C., Boscarino, J.A., Henkle, E.M., Nerenz, D.R., Denniston, M.M., Holmberg, S.D.","Hepatitis B and C virus infection among 1.2 million persons with access to care: Factors associated with testing and infection prevalence",2012,"Clinical Infectious Diseases","55","8",,"1047","1055",,86,10.1093/cid/cis616,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866667687&doi=10.1093%2fcid%2fcis616&partnerID=40&md5=3ba94a9fe37139c1c3d4a2647512d6ea",Review,Scopus,2-s2.0-84866667687
"Jafri, S.-M., Gordon, S.C.","Second generation protease inhibitors and nucleotide inhibitors",2012,"Current Hepatitis Reports","11","3",,"172","180",,,10.1007/s11901-012-0137-3,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872193785&doi=10.1007%2fs11901-012-0137-3&partnerID=40&md5=5b05fe0ee91e372f6c7c32ded634f56b",Article,Scopus,2-s2.0-84872193785
"Poordad, F., Bronowicki, J., Gordon, S.C., Zeuzem, S., Jacobson, I.M., Sulkowski, M.S., Poynard, T., Morgan, T.R., Molony, C., Pedicone, L.D., Sings, H.L., Burroughs, M.H., Sniukiene, V., Boparai, N., Goteti, V.S., Brass, C.A., Albrecht, J.K., Bacon, B.R.","Factors that predict response of patients with hepatitis C virus infection to Boceprevir",2012,"Gastroenterology","143","3",,"608","618.e5",,149,10.1053/j.gastro.2012.05.011,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865494240&doi=10.1053%2fj.gastro.2012.05.011&partnerID=40&md5=b024d099d0b29ceda8b9d8169f1507ca",Article,Scopus,2-s2.0-84865494240
"Tapper, E.B., Cohen, E.B., Patel, K., Bacon, B., Gordon, S., Lawitz, E., Nelson, D., Nasser, I.A., Challies, T., Afdhal, N.","Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients With Chronic Hepatitis C Virus Infection",2012,"Clinical Gastroenterology and Hepatology","10","8",,"932","937",,45,10.1016/j.cgh.2012.01.015,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84864075943&doi=10.1016%2fj.cgh.2012.01.015&partnerID=40&md5=ed41e75c8a4af12c9db68fbf66f46fa2",Article,Scopus,2-s2.0-84864075943
"Segovia, M.C., Chacra, W., Gordon, S.C.","Adefovir dipivoxil in chronic hepatitis B: History and current uses",2012,"Expert Opinion on Pharmacotherapy","13","2",,"245","254",,17,10.1517/14656566.2012.649727,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855882090&doi=10.1517%2f14656566.2012.649727&partnerID=40&md5=fe69e96c517429ad55bf99634c8a67f6",Review,Scopus,2-s2.0-84855882090
"Gordon, S.C., Patel, H.K.","Hepatic Manifestations of Systemic Disorders",2011,"Schiff's Diseases of the Liver",,,,"232","254",,,10.1002/9781119950509.ch9,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84886464262&doi=10.1002%2f9781119950509.ch9&partnerID=40&md5=2d23d633ba2aa701e6729ae46eb83f2d",Book Chapter,Scopus,2-s2.0-84886464262
"Gordon, S.C.","Utility of IL-28B polymorphisms in the era of direct-acting antiviral therapy",2011,"Gastroenterology and Hepatology","7","8",,"531","533",,1,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052632967&partnerID=40&md5=fd69d6895e1e18be8f41dee4ab4ff954",Note,Scopus,2-s2.0-80052632967
"Muir, A.J., Hu, K.-Q., Gordon, S.C., Koury, K., Boparai, N., Noviello, S., Albrecht, J.K., Sulkowski, M.S., McCone, J.","Hepatitis C treatment among racial and ethnic groups in the IDEAL trial",2011,"Journal of Viral Hepatitis","18","4",,"e134","e143",,24,10.1111/j.1365-2893.2010.01402.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952688660&doi=10.1111%2fj.1365-2893.2010.01402.x&partnerID=40&md5=a65f326539d250303617dd33fb93cab0",Article,Scopus,2-s2.0-79952688660
"Bacon, B.R., Gordon, S.C., Lawitz, E., Marcellin, P., Vierling, J.M., Zeuzem, S., Poordad, F., Goodman, Z.D., Sings, H.L., Boparai, N., Burroughs, M., Brass, C.A., Albrecht, J.K., Esteban, R.","Boceprevir for previously treated chronic HCV genotype 1 infection",2011,"New England Journal of Medicine","364","13",,"1207","1217",,1375,10.1056/NEJMoa1009482,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953176289&doi=10.1056%2fNEJMoa1009482&partnerID=40&md5=88ea321b126a415d18ebccbde15dbffa",Article,Scopus,2-s2.0-79953176289
"Poordad, F., McCone, J., Bacon, B.R., Bruno, S., Manns, M.P., Sulkowski, M.S., Jacobson, I.M., Reddy, K.R., Goodman, Z.D., Boparai, N., DiNubile, M.J., Sniukiene, V., Brass, C.A., Albrecht, J.K., Bronowicki, J.-P., Colombato, L., Curciarello, J., Silva, M., Tanno, H., Terg, R., Adler, M., Langlet, P., Lasser, L., Nevens, F., Anderson, F., Bailey, R., Bilodeau, M., Cooper, C., Feinman, S.V., Heathcote, J., Levstik, M., Ramji, A., Sherman, M., Shafran, S., Yoshida, E., Achim, A., Ben Ali, S., Bigard, M.-A., Bonny, C., Bourliere, M., Boyer-Darrigrand, N., Canva, V., Couzigou, P., De Ledinghen, V., Guyader, D., Hezode, C., Larrey, D., Latournerie, M., Marcellin, P., Mathurin, P., Maynard-Muet, M., Moussalli, J., Poupon, R., Poynard, T., Serfaty, L., Tran, A., Trepo, C., Truchi, R., Zarski, J.-P., Berg, T., Dikopoulos, N., Eisenbach, C., Galle, P.R., Gerken, G., Goeser, T., Gregor, M., Klass, D., Kraus, M.R., Niederau, C., Schlaak, J.F., Schmid, R., Thies, P., Schmidt, K., Thimme, R., Weidenbach, H., Zeuzem, S., Angelico, M., Carosi, G., Craxì, A., Mangia, A., Pirisi, M., Rizzetto, M., Taliani, G., Zignego, A.L., Reesink, H.W., Serejo, F., Reymunde, A., Rosado, B., Torres, E., Barcena Marugan, R., De La Mata, M., Calleja, J.L., Castellano, G., Diago, M., Esteban, R., Fernandez-Rodriguez, C., Sanchez Tapias, J., Serra Desfilis, M.A., Afdhal, N., Al-Osaimi, A., Balart, L., Bennett, M., Bernstein, D., Black, M., Bowlus, C., Boyer, T., Dalke, D., Davis, C., Davis, G., Davis, M., Everson, G., Felizarta, F., Flamm, S., Freilich, B., Galati, J., Galler, G., Ghalib, R., Gibas, A., Godofsky, E., Gordon, F., Gordon, S., Gross, J., Harrison, S., Herrera, J., Herrine, S., Hu, K.-Q., Imperial, J., Jones, D., Kilby, A., King, J., Koch, A., Kowdley, K., Krawitt, E., Kwo, P., Lambiase, L., Lawitz, E., Lee, W., Levin, J., Levine, R., Li, X., Lok, A., Luketic, V., Mailliard, M., McHutchison, J., Mikolich, D., Morgan, T., Muir, A., Nelson, D., Nunes, F., Nyberg, A., Nyberg, L., Pandya, P., Pauly, M.P., Peine, C., Poleynard, G., Pound, D., Poulos, J., Rabinovitz, M., Ravendhran, N., Ready, J., Reindollar, R., Reuben, A., Riley, T., Rossaro, L., Rubin, R., Ryan, M., Santoro, J., Schiff, E., Sepe, T., Sherman, K., Shiffman, M., Sjogren, M., Sjogren, R., Smith, C., Stein, L., Strauss, R., Szyjkowski, R., Vargas, H., Vierling, J., Witt, D., Yapp, R., Younes, Z.","Boceprevir for untreated chronic HCV genotype 1 infection",2011,"New England Journal of Medicine","364","13",,"1195","1206",,1989,10.1056/NEJMoa1010494,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953173221&doi=10.1056%2fNEJMoa1010494&partnerID=40&md5=91216ca6bf9b6a9f3c9d1de4645cb535",Article,Scopus,2-s2.0-79953173221
"Mitchell, M.M., Lleo, A., Zammataro, L., Mayo, M.J., Invernizzi, P., Bach, N., Shimoda, S., Gordon, S.C., Podda, M., Eric Gershwin, M., Selmi, C., LaSalle, J.M.","Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis",2011,"Epigenetics","6","1",,"95","102",,48,10.4161/epi.6.1.13405,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-78651238248&doi=10.4161%2fepi.6.1.13405&partnerID=40&md5=de78b380a7c758dc8b11322ec3055ed4",Article,Scopus,2-s2.0-78651238248
"Muir, A.J., Shiffman, M.L., Zaman, A., Yoffe, B., De La Torre, A., Flamm, S., Gordon, S.C., Marotta, P., Vierling, J.M., Lopez-Talavera, J.C., Byrnes-Blake, K., Fontana, D., Freeman, J., Gray, T., Hausman, D., Hunder, N.N., Lawitz, E.","Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection",2010,"Hepatology","52","3",,"822","832",,176,10.1002/hep.23743,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955873433&doi=10.1002%2fhep.23743&partnerID=40&md5=7af53faf6468a796d9ac91707f3e99a7",Article,Scopus,2-s2.0-77955873433
"Kwo, P.Y., Lawitz, E.J., McCone, J., Schiff, E.R., Vierling, J.M., Pound, D., Davis, M.N., Galati, J.S., Gordon, S.C., Ravendhran, N., Rossaro, L., Anderson, F.H., Jacobson, I.M., Rubin, R., Koury, K., Pedicone, L.D., Brass, C.A., Chaudhri, E., Albrecht, J.K.","Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): An open-label, randomised, multicentre phase 2 trial",2010,"The Lancet","376","9742",,"705","716",,566,10.1016/S0140-6736(10)60934-8,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956268467&doi=10.1016%2fS0140-6736%2810%2960934-8&partnerID=40&md5=bfe1aa83cafcb768feed20ca1ca12953",Article,Scopus,2-s2.0-77956268467
"Gordon, S.C., Moonka, D., Brown, K.A., Rogers, C., Huang, M.A.Y., Bhatt, N., Lamerato, L.","Risk for renal cell carcinoma in chronic hepatitis C infection",2010,"Cancer Epidemiology Biomarkers and Prevention","19","4",,"1066","1073",,28,10.1158/1055-9965.EPI-09-1275,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950845379&doi=10.1158%2f1055-9965.EPI-09-1275&partnerID=40&md5=dcc12654e5519dc6fb5c7055166ca3d8",Article,Scopus,2-s2.0-77950845379
"Wu, I.-C., Lai, C.-L., Bui Han, S.-H., Han, K.-H., Gordon, S.C., Chao, Y.-C., Tan, C.-K., Sievert, W., Tanwandee, T., Xu, D., Neo, B.-L., Chang, T.-T.","Efficacy of entecavir in chronic hepatitis b patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage",2010,"Hepatology","51","4",,"1185","1189",,28,10.1002/hep.23424,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950609092&doi=10.1002%2fhep.23424&partnerID=40&md5=ef1f8247874aea200a92c2141640f99d",Article,Scopus,2-s2.0-77950609092
"Rustgi, V.K., Lee, W.M., Lawitz, E., Gordon, S.C., Afdhal, N., Poordad, F., Bonkovsky, H.L., Bengtsson, L., Chandorkar, G., Harding, M., McNair, L., Aalyson, M., Alam, J., Kauffman, R., Gharakhanian, S., McHutchison, J.G.","Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders",2009,"Hepatology","50","6",,"1719","1726",,9,10.1002/hep.23204,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-73149087938&doi=10.1002%2fhep.23204&partnerID=40&md5=b24e0dde1efae706a2fec6abd3186ebb",Article,Scopus,2-s2.0-73149087938
"Feng, Z.-Z., Tang, J., Kim, D.Y., Brown, K., Abouljoud, M., Gordon, S., Yoshida, A., Huang, M.A., Divine, G., Moonka, D.K.","Renal insufficiency after liver transplantation in the MELD era compared to the pre-MELD era",2009,"Clinical Transplantation","23","5",,"637","642",,3,10.1111/j.1399-0012.2009.01020.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-70350145289&doi=10.1111%2fj.1399-0012.2009.01020.x&partnerID=40&md5=ea1b37ac802aee4f0ff779fa77739e31",Article,Scopus,2-s2.0-70350145289
"Krishnan, P.V., Feng, Z.-Z., Gordon, S.C.","Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements",2009,"Journal of Clinical Gastroenterology","43","7",,"672","675",,27,10.1097/MCG.0b013e318188be6d,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-68949100230&doi=10.1097%2fMCG.0b013e318188be6d&partnerID=40&md5=756a8eddbd3268b846feeae0270fd075",Article,Scopus,2-s2.0-68949100230
"Cheng, R., Barton, J.C., Morrison, E.D., Phatak, P.D., Krawitt, E.L., Gordon, S.C., Kowdley, K.V.","Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes",2009,"Journal of Clinical Gastroenterology","43","6",,"569","573",,18,10.1097/MCG.0b013e3181919a33,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-67651115587&doi=10.1097%2fMCG.0b013e3181919a33&partnerID=40&md5=138cdbe7803cefebb4c0c57be869738a",Article,Scopus,2-s2.0-67651115587
"Gish, R.G., Gordon, S.C., Nelson, D., Rustgi, V., Rios, I.","A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma",2009,"Hepatology International","3","3",,"480","489",,15,10.1007/s12072-009-9132-3,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-68949151592&doi=10.1007%2fs12072-009-9132-3&partnerID=40&md5=ec59482237abfd81c22c7e2c99c5b438",Article,Scopus,2-s2.0-68949151592
"McHutchison, J.G., Everson, G.T., Gordon, S.C., Jacobson, I.M., Sulkowski, M., Kauffman, R., McNair, L., Alam, J., Muir, A.J.","Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection",2009,"New England Journal of Medicine","360","18",,"1827","1838",,942,10.1056/NEJMoa0806104,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-65449152185&doi=10.1056%2fNEJMoa0806104&partnerID=40&md5=65c9cfb7049c83648ba8e6346be87a06",Article,Scopus,2-s2.0-65449152185
"Gordon, S.C., Sherman, K.E.","Treatment of HBV/HCV Coinfection: Releasing the Enemy Within",2009,"Gastroenterology","136","2",,"393","396",,13,10.1053/j.gastro.2008.12.017,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-58649101395&doi=10.1053%2fj.gastro.2008.12.017&partnerID=40&md5=572843d194ddb22004cec216fb9a5ecf",Editorial,Scopus,2-s2.0-58649101395
"Bernstein, D.E., Bzowej, N., Gordon, S.C., Hassanein, T., Jensen, D., Martin, P., Morgan, T.R., Rossaro, L.","Erratum: ""R1626 plus peginterferon alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin"" (Hepatology (2008) vol. 48 (385-397) 10.1002/hep.22357)",2008,"Hepatology","48","6",,"2093","",,,10.1002/hep.22713,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-65649088334&doi=10.1002%2fhep.22713&partnerID=40&md5=8d4a5aac9225c23547805718171dbe02",Erratum,Scopus,2-s2.0-65649088334
"Antaki, F., French, M.M., Moonka, D.K., Gordon, S.C.","Bioelectrical impedance analysis for the evaluation of hepatic fibrosis in patients with chronic hepatitis C infection",2008,"Digestive Diseases and Sciences","53","7",,"1957","1960",,16,10.1007/s10620-007-0071-3,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-44449127241&doi=10.1007%2fs10620-007-0071-3&partnerID=40&md5=7a46badd3c450624eebf1e1164d5a37d",Article,Scopus,2-s2.0-44449127241
"Weegink, C.J., Forestier, N., Jansen, P.L., Zeuzem, S., Reesink, H.W., Jacobson, I.M., Everson, G.T., Gordon, S.C., Kauffman, R., McNair, L., Muir, A., McHutchison, J.G., Hezode, C., Ferenci, P., Dusheiko, G.M., Pol, S., Goeser, T., Bronowicki, J.P., Gharakhanian, S., Devonish, D., Kauffman, R., Alam, J., Pawlotsky, J.M., Zeuzem, S., Kieffer, T., Zhou, Y., Zhang, E., Marcial, M., Byrn, R., Pfeiffer, T., Miller, J., Tigges, A., Bartels, D., Kwong, A., Ferenci, P., Dusheiko, G., Zeuzem, S., Pawlotsky, J.M., Standring, D.N., Bichko, V., Chase, R., LaColla, M., Lallos, L., Skelton, A., Soukasakos, M., Tausek, M., Tong, X., Ralston, R., Poordad, F., Lawitz, E.J., Gitlin, N., Rodriguez-Torres, M., Box, T., Nguyen, T., Pietropaolo, K., Liu, W., Fielman, B.A., Mayers, D., Pockros, P.J., Nelson, D., Godofsky, E., Rodriguez-Torres, M., Everson, G., Fried, M.W., Ghalib, R.H., Harrison, S.A., Nyberg, L.M., Shiffman, M.L., Hill, G.Z., Chan, A.","Novel protease and polymerase inhibiting agents to treat chronic hepatitis C infection",2008,"Gastroenterology and Hepatology","4","2 SUPPL. 6",,"5","13",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-41149101854&partnerID=40&md5=ddbc18e87146180307e8208434c580b8",Conference Paper,Scopus,2-s2.0-41149101854
"McHutchison, J.G., Dusheiko, G., Shiffman, M.L., Rodriguez-Torres, M., Sigal, S., Bourliere, M., Berg, T., Gordon, S.C., Campbell, F.M., Theodore, D., Blackman, N., Jenkins, J., Afdhal, N.H.","Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C",2007,"New England Journal of Medicine","357","22",,"2227","2236",,324,10.1056/NEJMoa073255,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-36549047972&doi=10.1056%2fNEJMoa073255&partnerID=40&md5=493cc874f33647f62c7f7dbcc7753dc9",Article,Scopus,2-s2.0-36549047972
"McHutchison, J.G., Bacon, B.R., Gordon, S.C., Lawitz, E., Shiffman, M., Afdhal, N.H., Jacobson, I.M., Muir, A., Al-Adhami, M., Morris, M.L., Lekstrom-Himes, J.A., Efler, S.M., Davis, H.L.","Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus",2007,"Hepatology","46","5",,"1341","1349",,92,10.1002/hep.21773,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-36348931521&doi=10.1002%2fhep.21773&partnerID=40&md5=b7a6b0b909aae49389ac889ea37ffcd0",Article,Scopus,2-s2.0-36348931521
"Jacobson, I.M., Brown Jr., R.S., Freilich, B., Afdhal, N., Kwo, P.Y., Santoro, J., Becker, S., Wakil, A.E., Pound, D., Godofsky, E., Strauss, R., Bernstein, D., Flamm, S., Pauly, M.P., Mukhopadhyay, P., Griffel, L.H., Brass, C.A., Black, M., Fried, M., Dies, D., Brodsky, N., Cerulli, M., Esposito, S., Rahmin, M., David, J., Lebovics, E., Kenny, R., Levendoglu, H., Ozick, L., Gardner, P., Berman, D., Feldman, D., Tobias, H., Klion, F., Min, A., Ehrlich, J., Spivack, J., Stein, D., Kwo, P., VanDrake, V., Behrle, K., Serini, J., Monsour, H., Anand, B., Galler, G., Stribling, R., Kelly, S., Bala, N., McDonald, T., Ghosh, M., Gordon, F., Ades, A., Brand, M., Cooley, J., Epstein, A., Sepe, T., Abraham, G., Agrawal, R., Rabinovitz, M., Smith, M., Kilby, F., Nunes, D., Srour, J., Richter, S., Shick, L., Varunok, P., Zucker, G., Polito, J., Lyons, M., Maccini, D., Sahagun, G., Bedard, C., Wadland, D., Loura, F., Levin, A., Box, T., Tsai, N., Tolman, K., Baddoura, W., Bernstein, M.D., DePasquale, J., Bermanski, P., Gabbazaideh, D., Lake-Bakaar, G., Cowan, J., Hagendom, C., Fixelle, A., Rubin, R., Albert, C., Hudes, B., Murphy, M., Cochran, J.L., Herrera, J., Gitlin, N., Reindollar, R., Fenyves, J., Dye, K., Noble, T., Weprin, L., Epstein, M., Finkel, R., Ravendhran, N., Cox, M., Rai, R., Gelrud, L., Lobis, I., Ryan, M., Rustgi, V., Shiffman, M., Lewis, J., McCone, J., Kaplan, W., Hurwich, D., Goldman, D., Yapp, R., Te, H., Perez, R., Weston, A., Regenstein, F., Rinker, R., Dragutsky, M., Migicovsky, B., Herring, R., Ross, W., Lyles, W., Nelson, A., Cofrancesco, S., King, J., Allen, T., Bhandari, R., Gordon, S., Siddiqui, F., Peine, C., Gross, J., Lake, J., Kichner, J., Franco, J., Nelson, J., Levin, J., Ho, S., Smith, C., Levin, D., Henry, M., Dalke, D., Jensen, J., Kim, L., Levine, R., Goff, J., Brouillette, D., Lanspa, S., Manning, R., Harrison, S., Diamond, K., Davis, M., Nguyen, T., Vemuru, R., Cox, J., Ganeshappa, K., Matossian, H., Galen, E., Nader, P., Reddy, K.R., Matusow, G., Carlson, S., Szpakowski, J.L., Esrason, K., Pham, T.-V., Lee, A., Jenkins, T., Ready, J., Kam, N., Shlager, L., Pimstone, N., Cheung, R., Wong, H., Hargrave, T., Sylvestre, D., Devault, K., Aggarwal, A., Schwertner, D., Cavacini, T., Reisman, T., Lambiase, L., Ricci, D., Eisner, M., Rothman, S.L., Bloom, M., Berman, A., Yudelman, P., Wiesen, S., Shankar, M., Rosenfield, T., Vierling, J., Schulman, D., Han, S.-H., Lyche, K., Felizarta, F., Deguzman, L., Hillebrand, D., Bock, B., Tuan, T.N., Demicco, M., Woolf, G., Araya, V., Shaw, E., Stein, L., Digregorio, K., D'Angelo, C., Thornton, J., Chen, S., Jolley, J., Terrault, N., Gish, R., Wasserman, R., Layden, T., Van Thiel, D., Jensen, D., Levstik, M., Pruitt, R., Siciliano, G., Cecil, B., Marsano, L., Jonas, M., Knapple, W., Balan, V., Meline, D., Palley, S., Rigberg, L., Winston, D., Hassanein, T.","Peginterferon alfa-2b and Weight-Based or Flat-Dose Ribavirin in Chronic Hepatitis C Patients: A Randomized Trial",2007,"Hepatology","46","4",,"971","981",,243,10.1002/hep.21932,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-36348981708&doi=10.1002%2fhep.21932&partnerID=40&md5=4cd9b3ea5c2e7d5755ba4b630d32172d",Article,Scopus,2-s2.0-36348981708
"Kim, D.Y., Lim, C., Parasuraman, R., Raoufi, M., Yoshida, A., Arenas, J., Denny, J., Malinzak, L., Almarastani, M., Moonka, D., Brown, K., Sherbondy, M., Gordon, S., Abouljoud, M.","Renal Disease Burden Following Liver Transplantation",2006,"Transplantation Proceedings","38","10",,"3663","3665",,21,10.1016/j.transproceed.2006.10.054,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33845427949&doi=10.1016%2fj.transproceed.2006.10.054&partnerID=40&md5=6a6ed947c135525f71f79a3e03cdf6cf",Article,Scopus,2-s2.0-33845427949
"Toubi, E., Gordon, S., Kessel, A., Rosner, I., Rozenbaum, M., Shoenfeld, Y., Zuckerman, E.","Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: Association with autoimmunity",2006,"Journal of Autoimmunity","27","2",,"134","139",,84,10.1016/j.jaut.2006.07.005,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749514258&doi=10.1016%2fj.jaut.2006.07.005&partnerID=40&md5=8dc3817881135cde8a585d5526d76710",Article,Scopus,2-s2.0-33749514258
"Salem, R., Lewandowski, R.J., Atassi, B., Gordon, S.C., Gates, V.L., Barakat, O., Sergie, Z., Wong, C.-Y.O., Thurston, K.G.","Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (therasphere): Safety, tumor response, and survival",2005,"Journal of Vascular and Interventional Radiology","16","12",,"1627","1639",,274,10.1097/01.RVI.0000184594.01661.81,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646102404&doi=10.1097%2f01.RVI.0000184594.01661.81&partnerID=40&md5=1efc38976675446d99c63ba172e59cb0",Article,Scopus,2-s2.0-33646102404
"McHutchison, J.G., Shiffman, M.L., Cheung, R.C., Gordon, S.C., Wright, T.L., Pottage Jr., J.C., McNair, L., Ette, E., Moseley, S., Alam, J.","A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-α in previously untreated patients with chronic hepatitis C",2005,"Antiviral Therapy","10","5",,"635","643",,30,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-24044538303&partnerID=40&md5=547e3b4cb355378d1ada7ca9f420075a",Article,Scopus,2-s2.0-24044538303
"Terrault, N.A., Pawlotsky, J.-M., McHutchison, J., Anderson, F., Krajden, M., Gordon, S., Zitron, I., Perrillo, R., Gish, R., Holodniy, M., Friesenhahn, M.","Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy",2005,"Journal of Viral Hepatitis","12","5",,"465","472",,21,10.1111/j.1365-2893.2005.00615.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-24044529162&doi=10.1111%2fj.1365-2893.2005.00615.x&partnerID=40&md5=cce0d88cd8fc111b5e3e0c86626ac583",Article,Scopus,2-s2.0-24044529162
"Gordon, S.C.","Occult viral hepatitis and noncirrhotic hepatocellular carcinoma",2005,"American Journal of Gastroenterology","100","8",,"1754","1757",,10,10.1111/j.1572-0241.2005.50483.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-25644437123&doi=10.1111%2fj.1572-0241.2005.50483.x&partnerID=40&md5=5c919cefd03ef4bc2fd913ece64417dd",Review,Scopus,2-s2.0-25644437123
"Rhee, T.K., Omary, R.A., Gates, V., Mounajjed, T., Larson, A.C., Barakat, O., Sato, K.T., Mulcahy, M., Gordon, S., Lewandowski, R.J., Salem, R.","The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma",2005,"Journal of Vascular and Interventional Radiology","16","8",,"1085","1091",,49,10.1097/01.RVI.0000177063.92678.21,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-23844546191&doi=10.1097%2f01.RVI.0000177063.92678.21&partnerID=40&md5=2267f27ce892cfad052fe3c33f7b3edc",Article,Scopus,2-s2.0-23844546191
"Kikuchi, K., Lian, Z.-X., Kimura, Y., Selmi, C., Yang, G.-X., Gordon, S.C., Invernizzi, P., Podda, M., Coppel, R.L., Ansari, A.A., Ikehara, S., Miyakawa, H., Gershwin, M.E.","Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis",2005,"Journal of Autoimmunity","24","4",,"347","352",,53,10.1016/j.jaut.2005.03.002,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-20144363210&doi=10.1016%2fj.jaut.2005.03.002&partnerID=40&md5=afe4ab105e442a30f745741d0b2b9d0c",Article,Scopus,2-s2.0-20144363210
"Ichiki, Y., Selmi, C., Shimoda, S., Ishibashi, H., Gordon, S.C., Gershwin, M.E.","Mitochondrial antigens as targets of cellular and humoral auto-immunity in primary biliary cirrhosis",2005,"Clinical Reviews in Allergy and Immunology","28","2",,"83","91",,9,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-24644522745&partnerID=40&md5=eeb1086489368e252f8e9c2aef907f33",Review,Scopus,2-s2.0-24644522745
"Goldstein, N.S., Hastah, F., Galan, M.V., Gordon, S.C.","Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens",2005,"American Journal of Clinical Pathology","123","3",,"382","387",,56,10.1309/EY72-F1EN-9XCB-1KXX,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-14644444565&doi=10.1309%2fEY72-F1EN-9XCB-1KXX&partnerID=40&md5=6ff8d340cd93c0146e8054b5899243a1",Review,Scopus,2-s2.0-14644444565
"Rulyak, S.J., Eng, S.C., Patel, K., McHutchison, J.G., Gordon, S.C., Kowdley, K.V.","Relationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirin",2005,"American Journal of Gastroenterology","100","2",,"332","337",,30,10.1111/j.1572-0241.2005.41112.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-13944256260&doi=10.1111%2fj.1572-0241.2005.41112.x&partnerID=40&md5=bbd727b4d3a7d8dbf8c3c4e4b2a4e313",Article,Scopus,2-s2.0-13944256260
"Galan, M.V., Potts, J.A., Silverman, A.L., Gordon, S.C.","Hepatitis in a United States tertiary referral center",2005,"Journal of Clinical Gastroenterology","39","1",,"64","67",,61,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-11144288739&partnerID=40&md5=5b47cbe54393dba4717c4c556461f80d",Review,Scopus,2-s2.0-11144288739
"Patel, K., Gordon, S.C., Jacobson, I., Hézode, C., Oh, E., Smith, K.M., Pawlotsky, J.-M., McHutchison, J.G.","Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients",2004,"Journal of Hepatology","41","6",,"935","942",,273,10.1016/j.jhep.2004.08.008,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-9644272496&doi=10.1016%2fj.jhep.2004.08.008&partnerID=40&md5=15fb12a6ad7b0120fb99e2a73be50f41",Article,Scopus,2-s2.0-9644272496
"Selmi, C., Mayo, M.J., Bach, N., Ishibashi, H., Invernizzi, P., Gish, R.G., Gordon, S.C., Wright, H.I., Zweiban, B., Podda, M., Gershwin, M.E.","Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment",2004,"Gastroenterology","127","2",,"485","492",,289,10.1053/j.gastro.2004.05.005,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-4143103585&doi=10.1053%2fj.gastro.2004.05.005&partnerID=40&md5=0797c8db51705f5c5aacff21a18173b3",Article,Scopus,2-s2.0-4143103585
"Jaeckel, E., Wedemeyer, H., Wiegand, J., Manns, M.P., Gerlach, J.T., Diepolder, H.M., Pape, G.R., Ulsenheimer, A., Gordon, S.C.","Acute Hepatitis C Virus Infection: To Treat or Not to Treat? [5] (multiple letters)",2004,"Gastroenterology","126","4",,"1219","1220",,6,10.1053/j.gastro.2004.02.041,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-1842583060&doi=10.1053%2fj.gastro.2004.02.041&partnerID=40&md5=9b9d92a1eaabb5ecce62b516f17bcbe1",Letter,Scopus,2-s2.0-1842583060
"Gordon, S.C.","New insights into acute hepatitis C",2003,"Gastroenterology","125","1",,"253","256",,15,10.1016/S0016-5085(03)00807-2,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038392464&doi=10.1016%2fS0016-5085%2803%2900807-2&partnerID=40&md5=94b88d51cecb1606fd825e2f8454de37",Editorial,Scopus,2-s2.0-0038392464
"Stecevic, V., Pevzner, M.M., Gordon, S.C.","Successful treatment of hepatitis B-associated vasculitis with lamivudine [1]",2003,"Journal of Clinical Gastroenterology","36","5",,"451","",,7,10.1097/00004836-200305000-00020,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0344059037&doi=10.1097%2f00004836-200305000-00020&partnerID=40&md5=b0efe90f59a5b07c3faef2515aa56b1a",Letter,Scopus,2-s2.0-0344059037
"Morrison, E.D., Brandhagen, D.J., Phatak, P.D., Barton, J.C., Krawitt, E.L., El-Serag, H.B., Gordon, S.C., Galan, M.V., Tung, B.Y., Ioannou, G.N., Kowdley, K.V.","Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis",2003,"Annals of Internal Medicine","138","8",,"627","633+I30",,116,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-1642494711&partnerID=40&md5=249189ba906509231b77f309525a0012",Article,Scopus,2-s2.0-1642494711
"Siebert, U., Sroczynski, G., Rossol, S., Wasem, J., Ravens-Sieberer, U., Kurth, B.M., Manns, M.P., McHutchison, J.G., Wong, J.B., Greiner, W., vonderSchulenburg, J.-M.G., Bullinger, M., Aidelsburger, P., Hessel, F., Buchner, F., Corzillius, M., Anderson, F.H., Arora, S., Bacon, B., Balart, L., Benner, K.G., Bigard, M.-A., Bodenheimer, H.C., Bourliere, M., Brechot, C., Brunner, H., Caldwell, S., Carey, W., Carithers, R.L., Davis, G.L., Dienstag, J., Donovan, J., Esteban-Mur, R., Buti, M., Everson, G.T., Feinman, S., Flamm, S., Galle, P.R., Gish, R., Gitlin, N., Goeser, T., Gordon, S., Greten, H., Hadzyiannis, S., Hokeberg, I., Jacobson, I., Kwo, P., LaBrecque, D.R., Lee, W.M., Lindgren, S., Lindsay, K.L., Manns, M.P., Marcellin, P., Marotta, P., McGarrity, T., McHutchison, J.G., Moreno, R., Morgan, T.R., Perrillo, R., Poliquin, M., Poynard, T., Rakela, J., Reindollar, R., Rodriguez-Agullo, J.L., Rouzier-Panis, R., Rustgi, V., Sanchez-Tapias, J.M., Schiff, E.R., Schuppan, D., Sherman, M., Shiffman, M.L., Silva, M., Smith, C., Tanno, H., Trepo, C., Vogel, W., Wright, T., Zeuzem, S.","Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C",2003,"Gut","52","3",,"425","432",,175,10.1136/gut.52.3.425,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037372609&doi=10.1136%2fgut.52.3.425&partnerID=40&md5=4d86e5f44087c4977c20951f92773936",Article,Scopus,2-s2.0-0037372609
"Pianko, S., Blatt, L.M., McHutchison, J.G., Gordon, S.C., Heaton, S., Goodman, Z.D., Patel, K., Cortese, C.M., Brunt, E.M., Bacon, B.R.","Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection",2002,"Journal of Interferon and Cytokine Research","22","4",,"483","489",,27,10.1089/10799900252952271,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036267134&doi=10.1089%2f10799900252952271&partnerID=40&md5=5258f83adef6ae3749da7581d75dcbc4",Article,Scopus,2-s2.0-0036267134
"Goldstein, N.S., Soman, A., Gordon, S.C.","Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis",2001,"American Journal of Clinical Pathology","116","6",,"846","853",,24,10.1309/VHHD-HTRU-N8J2-5X7R,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035184549&doi=10.1309%2fVHHD-HTRU-N8J2-5X7R&partnerID=40&md5=9aeec2ff3b4fa9db10fde8031ef41101",Article,Scopus,2-s2.0-0035184549
"Comanor, L., Anderson, F., Ghany, M., Perrillo, R., Heathcote, E.J., Sherlock, C., Zitron, I., Hendricks, D., Gordon, S.C.","Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment",2001,"American Journal of Gastroenterology","96","10",,"2968","2972",,53,10.1016/S0002-9270(01)03231-2,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034794365&doi=10.1016%2fS0002-9270%2801%2903231-2&partnerID=40&md5=24cfbe438fac4dfe9e76730c73604213",Article,Scopus,2-s2.0-0034794365
"Gordon, S.C.","Treatment of viral hepatitis - 2001",2001,"Annals of Medicine","33","6",,"385","390",,8,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034827076&partnerID=40&md5=d49a68295cfdeebf56dddbbdd441f159",Review,Scopus,2-s2.0-0034827076
"Manns, M.P., McHutchison, J.G., Gordon, S.C., Rustgi, V.K., Shiffman, M., Reindollar, R., Goodman, Z.D., Koury, K., Ling, M.-H., Albrecht, J.K.","Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial",2001,"Lancet","358","9286",,"958","965",,5498,10.1016/S0140-6736(01)06102-5,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035934568&doi=10.1016%2fS0140-6736%2801%2906102-5&partnerID=40&md5=3c41653e8f080884010c389768ea4b9f",Article,Scopus,2-s2.0-0035934568
"Galan, M.V., Boyce, D., Gordon, S.C.","Current pharmacotherapy for hepatitis B infection",2001,"Expert Opinion on Pharmacotherapy","2","8",,"1289","1298",,10,10.1517/14656566.2.8.1289,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034875869&doi=10.1517%2f14656566.2.8.1289&partnerID=40&md5=f449a1ae92a5b282dc0689a79e66d440",Review,Scopus,2-s2.0-0034875869
"Silverman, A.L., Qu, L.H., Blow, J., Zitron, I.M., Gordon, S.C., Walker, E.D.","Assessment of hepatitis B virus DNA and hepatitis C virus RNA in the common bedbug (Cimex lectularius L.) and kissing bug (Rodnius prolixus)",2001,"American Journal of Gastroenterology","96","7",,"2194","2198",,45,10.1016/S0002-9270(01)02518-7,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034931143&doi=10.1016%2fS0002-9270%2801%2902518-7&partnerID=40&md5=bd907050510721847d204a54211a9255",Article,Scopus,2-s2.0-0034931143
"Lazarczyk, D.A., Goldstein, N.S., Gordon, S.C.","Trovafloxacin hepatotoxicity",2001,"Digestive Diseases and Sciences","46","4",,"925","926",,31,10.1023/A:1010741510046,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035034433&doi=10.1023%2fA%3a1010741510046&partnerID=40&md5=4464df86dda9945ffbde3f0921f07d23",Article,Scopus,2-s2.0-0035034433
"Galan, M.V., Gordon, S.C., Silverman, A.L.","Celecoxib-induced cholestatic hepatitis [4]",2001,"Annals of Internal Medicine","134","3",,"254","",,42,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035814830&partnerID=40&md5=4fdb66d1f946971247307d15b108625b",Letter,Scopus,2-s2.0-0035814830
"McHutchison, J.G., Shad, J.A., Gordon, S.C., Morgan, T.R., Ling, M.-H., Garaud, J.-J., Albrecht, J.K., Dienstag, J.L.","Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy",2001,"Journal of Viral Hepatitis","8","6",,"414","420",,52,10.1046/j.1365-2893.2001.00312.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035552139&doi=10.1046%2fj.1365-2893.2001.00312.x&partnerID=40&md5=4dfd50db801f35f70a9e4bf830adc969",Article,Scopus,2-s2.0-0035552139
"Lindsay, K.L., Trepo, C., Heintges, T., Shiffman, M.L., Gordon, S.C., Hoefs, J.C., Schiff, E.R., Goodman, Z.D., Laughlin, M., Yao, R., Albrecht, J.K.","A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C",2001,"Hepatology","34","2",,"395","403",,622,10.1053/jhep.2001.26371,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-17844403232&doi=10.1053%2fjhep.2001.26371&partnerID=40&md5=6cbe60f229a4c36772f2a75dc16afc6b",Article,Scopus,2-s2.0-17844403232
"Goldstein, N.S., Bayati, N., Silverman, A.L., Gordon, S.C.","Minocycline as a cause of drug-induced autoimmune hepatitis: Report of four cases and comparison with autoimmune hepatitis",2000,"American Journal of Clinical Pathology","114","4",,"591","598",,49,10.1309/KV2J-VX6Q-L95V-VDE4,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034424831&doi=10.1309%2fKV2J-VX6Q-L95V-VDE4&partnerID=40&md5=06eff50baf0b7809aad0a890298663ea",Article,Scopus,2-s2.0-0034424831
"Zitron, I.M., Laurinaitis, M., Qu, L., Silverman, A.L., Gordon, S.C.","Immunological responses in patients who have spontaneously eradicated hepatitis C virus infection",2000,"Viral Immunology","13","4",,"521","531",,2,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034510547&partnerID=40&md5=288ee16e9c872943615928886bfba5bb",Article,Scopus,2-s2.0-0034510547
"McHutchison, J.G., Poynard, T., Pianko, S., Gordon, S.C, Reid, A.E, Dienstag, J., Morgan, T., Albrecht, J.","The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C",2000,"Gastroenterology","119","5",,"1317","1323",,163,10.1053/gast.2000.19289,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034322373&doi=10.1053%2fgast.2000.19289&partnerID=40&md5=2d0d442a04ead7a9beb2973877d240cf",Article,Scopus,2-s2.0-0034322373
"Gordon, S.C., Fang, J.W., Silverman, A.L., McHutchison, J.G., Albrecht, J.K.","The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C",2000,"Hepatology","32","2",,"400","404",,70,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033853927&partnerID=40&md5=dc72045d0f73819a7221e0ffd4bb6d7c",Article,Scopus,2-s2.0-0033853927
"Silverman, A.L., Sekhon, J.S., Saginaw, S.J., Wiedbrauk, D., Balasubramaniam, M., Gordon, S.C.","Tattoo application is not associated with an increased risk for chronic viral hepatitis",2000,"American Journal of Gastroenterology","95","5",,"1312","1315",,19,10.1016/S0002-9270(00)00823-6,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034061014&doi=10.1016%2fS0002-9270%2800%2900823-6&partnerID=40&md5=888747dfab1b7888c50c2310d46c685c",Article,Scopus,2-s2.0-0034061014
"Gordon, S.C.","Antiviral therapy for chronic hepatitis B and C: Which patients are likely to benefit from which agents?",2000,"Postgraduate Medicine","107","2",,"135","144",,5,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033962279&partnerID=40&md5=532df37bc96e27cfc38d6ab87320325f",Conference Paper,Scopus,2-s2.0-0033962279
"Gordon, S.C.","Erratum: Antiviral therapy for chronic hepatitis B and C: Which patients are likely to benefit from which agents? (Postgraduate Medicine (February) (142))",2000,"Postgraduate Medicine","107","4",,"24","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033994287&partnerID=40&md5=313f452907594477d40510d4ad1969b6",Erratum,Scopus,2-s2.0-0033994287
"Gordon, S.C.","Does the source of infection affect outcome of hepatitis C?",1999,"Viral Hepatitis Reviews","5","4",,"205","218",,3,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033367919&partnerID=40&md5=0fce941f8ca177963ade48065f48ea92",Short Survey,Scopus,2-s2.0-0033367919
"Mutchnick, M.G., Lindsay, K.L., Schiff, E.R., Cummings, G.D., Appelman, H.D., Peleman, R.R., Silva, M., Roach, K.C., Simmons, F., Milstein, S., Gordon, S.C., Ehrinpreis, M.N.","Thymosin α1 treatment of chronic hepatitis B: Results of a phase III multicentre, randomized, double-blind and placebo-controlled study",1999,"Journal of Viral Hepatitis","6","5",,"397","403",,54,10.1046/j.1365-2893.1999.00181.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032585756&doi=10.1046%2fj.1365-2893.1999.00181.x&partnerID=40&md5=9fda7a2736c83b63cca57b1ca102fc0d",Article,Scopus,2-s2.0-0032585756
"Goldstein, N.S., Blue, D.E., Hankin, R., Hunter, S., Bayati, N., Silverman, A.L., Gordon, S.C.","Serum α-fetoprotein levels in patients with chronic hepatitis C: Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores",1999,"American Journal of Clinical Pathology","111","6",,"811","816",,50,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032970057&partnerID=40&md5=fa484d459e3dcba12bdbc00bcce39b52",Article,Scopus,2-s2.0-0032970057
"Dowling, D., Gordon, S.C., Bayati, N., Silverman, A.L.","Mode of transmission of hepatitis C and clinical outcome correction [3] (multiple letters)",1999,"Hepatology","29","1",,"298","299",,1,10.1002/hep.510290136,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032951875&doi=10.1002%2fhep.510290136&partnerID=40&md5=647a4a431fd3da2cc6ae096420eb8895",Letter,Scopus,2-s2.0-0032951875
"Gordon, S.C., Dailey, P.J., Silverman, A.L., Khan, B.A., Kodali, V.P., Wilber, J.C.","Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification",1998,"Hepatology","28","6",,"1702","1706",,37,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031768871&partnerID=40&md5=fab2d993bc5b575483b417f979afffbe",Article,Scopus,2-s2.0-0031768871
"Bayati, N., Silverman, A.L., Gordon, S.C.","Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C",1998,"American Journal of Gastroenterology","93","12",,"2452","2456",,95,10.1111/j.1572-0241.1998.00703.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038023128&doi=10.1111%2fj.1572-0241.1998.00703.x&partnerID=40&md5=dfa608a610b871b6de7125a926dafd9c",Article,Scopus,2-s2.0-0038023128
"Mchutchison, J.G., Gordon, S.C., Schiff, E.R., Shiffman, M.L., Lee, W.M., Rustgi, V.K., Goodman, Z.D., Ling, M.-H., Cort, S., Albrecht, J.K.","Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C",1998,"New England Journal of Medicine","339","21",,"1485","1492",,3150,10.1056/NEJM199811193392101,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032547938&doi=10.1056%2fNEJM199811193392101&partnerID=40&md5=738e4be1f4d2e684e653eafa0cb68157",Article,Scopus,2-s2.0-0032547938
"Davis, G.L., Esteban-Mur, R., Rustgi, V., Hoefs, J., Gordon, S.C., Trepo, C., Shiffman, M.L., Zeuzem, S., Craxi, A., Ling, M.-H., Albrecht, J.","Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C",1998,"New England Journal of Medicine","339","21",,"1493","1499",,1252,10.1056/NEJM199811193392102,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032547944&doi=10.1056%2fNEJM199811193392102&partnerID=40&md5=4ffdbd30052b2d82acb7f7f1dcc47dc3",Article,Scopus,2-s2.0-0032547944
"Gordon, S.C., Bayati, N., Silverman, A.L.","Clinical outcome of hepatitis C as a function of mode of transmission",1998,"Hepatology","28","2",,"562","567",,94,10.1002/hep.510280238,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031927737&doi=10.1002%2fhep.510280238&partnerID=40&md5=4f391373928fe4f82b0b67736cc5e990",Article,Scopus,2-s2.0-0031927737
"Goldstein, N.S., Underhill, J., Gordon, S.C., Bayati, N., Silverman, A.","Comparative histologic features of liver biopsy specimens from patients coinfected with hepatitis G and C viruses with chronic hepatitis C virus alone: An age-, sex-, disease duration-, and transmission-matched controlled study of chronic hepatitis",1997,"American Journal of Clinical Pathology","108","6",,"625","632",,9,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030667184&partnerID=40&md5=0b7e9ef39b40f5a1ac0c051166fbda91",Article,Scopus,2-s2.0-0030667184
"Silverman, A.L., Piquette, D.L., Filipiak, C.L., Neill, J.S., Bayati, N., Gordon, S.C.","Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels",1997,"American Journal of Gastroenterology","92","10",,"1793","1795",,33,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030767251&partnerID=40&md5=880e91dbc09b970f872a5c8bec18531c",Article,Scopus,2-s2.0-0030767251
"Simon, D.M., Gordon, S.C., Kaplan, M.M., Koff, R.S., Regenstein, F., Everson, G., Lee, Y.M., Weiner, F., Silverman, A., Plasse, T., Fedorczyk, D., Liao, M.-J.","Treatment of chronic hepatitis C with interferon alfa-n3: A multicenter, randomized, open-label trial",1997,"Hepatology","25","2",,"445","448",,16,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-12644274686&partnerID=40&md5=d391ca1c8880e1ce5faa8b8d1c56279a",Article,Scopus,2-s2.0-12644274686
"Kiechle, F.L., Quattrociocchi-Longe, T.M., Brinton, D.A., Gordon, S.C., Sykes, E., Elkhalifa, M.Y.","Autoantibodies to specific enzymes: A review",1996,"Annals of Clinical and Laboratory Science","26","3",,"195","207",,10,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029963049&partnerID=40&md5=ef3f639d43defec29305355d24c724c2",Review,Scopus,2-s2.0-0029963049
"Gordon, S., Bensen, S., Smith, R.","Long term follow-up of older patients with iron deficiency anemia after a negative GI evaluation",1996,"American Journal of Gastroenterology","91","5",,"885","889",,46,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029885791&partnerID=40&md5=53cd19547510fc56a5e765ef55777f72",Article,Scopus,2-s2.0-0029885791
"Silverman, A.L., McCray, D.G., Gordon, S.C., Morgan, W.T., Walker, E.D.","Experimental Evidence Against Replication or Dissemination of Hepatitis C Virus in Mosquitoes (Diptera: Culicidae) Using Detection by Reverse Transcriptase Polymerase Chain Reaction",1996,"Journal of Medical Entomology","33","3",,"398","401",,9,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030136678&partnerID=40&md5=bb7d22e368a79ecae2e496ca10cd9c26",Article,Scopus,2-s2.0-0030136678
"Gordon, S.C.","Extrahepatic manifestations of hepatitis C",1996,"Digestive Diseases","14","3",,"157","168",,73,10.1159/000171547,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030133050&doi=10.1159%2f000171547&partnerID=40&md5=bca9c8d7e21f470657503a1931f26183",Article,Scopus,2-s2.0-0030133050
"Kodali, V.P., Gordon, S.C.","Gastrointestinal hemorrhage secondary to crack cocaine",1995,"Gastrointestinal Endoscopy","41","6",,"604","605",,8,10.1016/S0016-5107(95)70201-6,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029035103&doi=10.1016%2fS0016-5107%2895%2970201-6&partnerID=40&md5=194cf3b240c8b6f30d805feecb9d2031",Article,Scopus,2-s2.0-0029035103
"Goldstein, N.S., Kodali, V.P., Gordon, S.C.","Histologic spectrum of cryptogenic chronic liver disease and comparison with chronic autoimmune and chronic type C hepatitis",1995,"American Journal of Clinical Pathology","104","5",,"567","573",,12,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028809648&partnerID=40&md5=22c3a1dafbf32d8b1700f24f4d93a76e",Article,Scopus,2-s2.0-0028809648
"Gordon, S.C., Quattrociocchi-Longe, T.M., Khan, B.A., Kodali, V.P., Chen, J., Silverman, A.L., Kiechle, F.L.","Antibodies to carbonic anhydrase in patients with immune cholangiopathies",1995,"Gastroenterology","108","6",,"1802","1809",,89,10.1016/0016-5085(95)90143-4,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029052302&doi=10.1016%2f0016-5085%2895%2990143-4&partnerID=40&md5=b355f03c050c4c8c82679961e1ecd0d7",Article,Scopus,2-s2.0-0029052302
"Kodali, V.P., Gordon, S.C., Silverman, A.L., McCray, D.G.","Cryptogenic Liver Disease in the United States: Further Evidence for Non‐A, Non‐B, and Non‐C Hepatitis",1994,"The American Journal of Gastroenterology","89","10",,"1836","1839",,107,10.1111/j.1572-0241.1994.tb07703.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028116937&doi=10.1111%2fj.1572-0241.1994.tb07703.x&partnerID=40&md5=3505dec4ca4ddc734293a75425d44da1",Article,Scopus,2-s2.0-0028116937
"Silverman, A.L., Puccio, J.E., Kulesza, G.W., McCray, D.G., Gordon, S.C.","HCV RNA is Present in the Menstrual Blood of Women with Chronic Hepatitis C Infection",1994,"The American Journal of Gastroenterology","89","8",,"1201","1202",,26,10.1111/j.1572-0241.1994.tb10275.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027934184&doi=10.1111%2fj.1572-0241.1994.tb10275.x&partnerID=40&md5=2c04a0d8ad1d1c21e8296dea2ebd2111",Article,Scopus,2-s2.0-0027934184
"Gordon, S.C., Kodali, V.P., Silverman, A.L., Dmuchowski, C.F., Urdea, M.S., Chan, C.S., Wilber, J.C.","Levels of Hepatitis C Virus RNA and Liver Histology in Chronic Type C Hepatitis",1994,"The American Journal of Gastroenterology","89","9",,"1458","1461",,54,10.1111/j.1572-0241.1994.tb09158.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028125307&doi=10.1111%2fj.1572-0241.1994.tb09158.x&partnerID=40&md5=80376188ee9f3fdc6cb27dff5c91af27",Article,Scopus,2-s2.0-0028125307
"Silverman, A.L., Gordon, S.C.","Clinical epidemiology and molecular biology of hepatitis C",1993,"Laboratory Medicine","24","10",,"656","659",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027507784&partnerID=40&md5=3a8998aa747feaababae883129295bb8",Conference Paper,Scopus,2-s2.0-0027507784
"Gordon, S.C., Elloway, R.S., Long, J.C., Dmuchowski, C.F.","The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs. Intravenous drug use",1993,"Hepatology","18","6",,"1338","1343",,132,10.1002/hep.1840180609,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027441925&doi=10.1002%2fhep.1840180609&partnerID=40&md5=7c3e4872af4074042e4849d09a36604f",Article,Scopus,2-s2.0-0027441925
"Barnes, R.E., Meyer, R.A., Gordon, S.C.","Prevalence of Anti‐HCV in Cryptogenic Cirrhosis in a Suburban Detroit Community",1992,"The American Journal of Gastroenterology","87","8",,"1001","1004",,7,10.1111/j.1572-0241.1992.tb02932.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026703413&doi=10.1111%2fj.1572-0241.1992.tb02932.x&partnerID=40&md5=d793a1d7e0dc116c7fd8f3f7514035b9",Article,Scopus,2-s2.0-0026703413
"Gordon, S.C., Meyer, R.A., Rosenberg, B.F.","Laparoscopic diagnosis of subcapsular hepatic hemorrhage in pre-eclamptic liver disease",1992,"Gastrointestinal Endoscopy","38","6",,"718","720",,,10.1016/S0016-5107(92)70576-8,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027081153&doi=10.1016%2fS0016-5107%2892%2970576-8&partnerID=40&md5=1dd798cea3e3e8ca4dd75157e4534ab8",Article,Scopus,2-s2.0-0027081153
"Gordon, S.C., Patel, A.H., Kulesza, G.W., Barnes, R.E., Silverman, A.L.","Lack of Evidence for the Heterosexual Transmission of Hepatitis C",1992,"The American Journal of Gastroenterology","87","12",,"1849","1851",,87,10.1111/j.1572-0241.1992.tb07322.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026483262&doi=10.1111%2fj.1572-0241.1992.tb07322.x&partnerID=40&md5=ea2b88eb43fe411447964ff7f68bd9be",Article,Scopus,2-s2.0-0026483262
"Elkhalifa, M.Y., Kiechle, F.L., Gordon, S.C., Chen, J., Poulik, M.D.","A flow cytometric method to detect anti-pyruvate dehydrogenase antibody in primary biliary cirrhosis",1992,"American Journal of Clinical Pathology","97","2",,"202","208",,10,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026529166&partnerID=40&md5=9bbf73094c812a4e332c3df909de5b75",Article,Scopus,2-s2.0-0026529166
"Gordon, S.C.","Jaundice and cholestasis: Some common and uncommon causes",1991,"Postgraduate Medicine","90","4",,"65","68+70",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025772993&partnerID=40&md5=a5716d7224f89c21ced8f34e805cce20",Article,Scopus,2-s2.0-0025772993
"Meyer, R.A., Gordon, S.C.","Epidemiology of Hepatitis C Virus Infection in a Suburban Detroit Community",1991,"The American Journal of Gastroenterology","86","9",,"1224","1226",,32,10.1111/j.1572-0241.1991.tb07258.x,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025941367&doi=10.1111%2fj.1572-0241.1991.tb07258.x&partnerID=40&md5=3e7ae7bb9bd5d8bbe55ccaa00bfef6fa",Article,Scopus,2-s2.0-0025941367
"Levinson, J.R., Gordon, S.C.","Liver diseases in the elderly",1991,"Clinics in Geriatric Medicine","7","2",,"371","385",,6,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025847688&partnerID=40&md5=d86f00100ab1f3c36f35cad493aaaf90",Article,Scopus,2-s2.0-0025847688
"Gordon, S.C., Polson, D.J., Shirkhoda, A.","Budd-chiari syndrome complicating pre-eclampsia: Diagnosis by magnetic resonance imaging",1991,"Journal of Clinical Gastroenterology","13","4",,"460","462",,10,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025745323&partnerID=40&md5=0e05b4c9ba8a53d84660c226c8aa16fa",Article,Scopus,2-s2.0-0025745323
"Gordon, S.C., Veneri, R.J., McFadden, R.F., Reddy, K.R., Schiff, E.R.","Major hemorrhage after percutaneous liver biopsy in patients with AIDS",1991,"Gastroenterology","100","6",,"1787","",,18,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025822043&partnerID=40&md5=40ce7319b5fb677e44eaae8a775c222f",Letter,Scopus,2-s2.0-0025822043
"Gordon, S.C., Watts, J.C., Veneri, R.J., Chandler, F.W.","Focal hepatic candidiasis with perihepatic adhesions: Laparoscopic and immunohistologic diagnosis",1990,"Gastroenterology","98","1",,"214","217",,10,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025159381&partnerID=40&md5=7f2440dcadc63e1c3db326d0fe92a7df",Article,Scopus,2-s2.0-0025159381
"Veneri, RobertJ., Gordon, StuartC.","CERVICAL COLUMNAR EPITHELIUM AND TYLOSIS",1989,"The Lancet","334","8654",,"105","",,1,10.1016/S0140-6736(89)90345-0,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024343423&doi=10.1016%2fS0140-6736%2889%2990345-0&partnerID=40&md5=4c628b40de933a13c41ba606938604d2",Letter,Scopus,2-s2.0-0024343423
"Patel, A.S., Gordon, S.C.","Large-volume paracentesis in outpatients.",1989,"Annals of internal medicine","110","4",,"325","326",,3,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024969615&partnerID=40&md5=7446898f285a31762bea97eb8ad436d0",Letter,Scopus,2-s2.0-0024969615
"Veneri, R.J., Gordon, S.C., Fink-Bennett, D.","Scintigraphic and culdoscopic diagnosis of bile peritonitis complicating liver biopsy",1989,"Journal of Clinical Gastroenterology","11","5",,"571","573",,4,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024438926&partnerID=40&md5=7e70ce3d7acf206304d350b38a21779a",Article,Scopus,2-s2.0-0024438926
"Gordon, S.C., Patel, A.S., Veneri, R.J., Keskey, K.A., Korotkin, S.M.","Case report: Acute type a hepatitis presenting with hypotension, bradycardia, and sinus arrest",1989,"Journal of Medical Virology","28","4",,"219","222",,3,10.1002/jmv.1890280404,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024464683&doi=10.1002%2fjmv.1890280404&partnerID=40&md5=562d91da935a44887da47c92b57c8bd0",Editorial,Scopus,2-s2.0-0024464683
"Veneri, R.J., Gordon, S.C.","Anabolic steroid-induced cholestasis: Choleretic response to corticosteroids",1988,"Journal of Clinical Gastroenterology","10","4",,"467","468",,11,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024060787&partnerID=40&md5=28022a5da19b6789c4061f234ba4474c",Letter,Scopus,2-s2.0-0024060787
"Gordon, S.C., Reddy, K.J., Livingstone, A.S., Jeffers, L.J., Schiff, E.R.","Resolution of a contraceptive-steroid--induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma",1986,"Annals of Internal Medicine","105","4",,"547","549",,97,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022514767&partnerID=40&md5=43f476ff2b57ae65037d700a1d8d6043",Article,Scopus,2-s2.0-0022514767
"Gordon, S.C., Rajender Reddy, K., Zeppa, R., Jeffers, L.J., Schiff, E.R.","Resection of metachronous hepatocellular carcinomas",1986,"Southern Medical Journal","79","12",,"1578","1582",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022987399&partnerID=40&md5=147ddc0d3d0a66a5e0dab83a4b00ea41",Article,Scopus,2-s2.0-0022987399
"Gordon, S.C., Rajender Reddy, K., Gould, E.E., McFadden, R., O'Brien, C., De Medina, M., Jeffers, L.J., Schiff, E.R.","The spectrum of liver disease in the acquired immunodeficiency syndrome",1986,"Journal of Hepatology","2","3",,"475","484",,71,10.1016/S0168-8278(86)80059-9,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022483538&doi=10.1016%2fS0168-8278%2886%2980059-9&partnerID=40&md5=fe896fa3ffcc65d04bdb923c5699dc69",Article,Scopus,2-s2.0-0022483538
"Gordon, S.C., Jeffers, L.J., De Medina, M.D., Reddy, K.R., Schiff, E.R.","Immunoglobulin M antibody to hepatitis B core antigen and fulminant hepatitis B.",1985,"Annals of Internal Medicine","102","3",,"415","416",,1,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022035187&partnerID=40&md5=77494c9cf57385c73d3d43d8250c98a9",Letter,Scopus,2-s2.0-0022035187
"Gordon, S.C., Rajender Reddy, K., Jeffers, L.J., Schiff, E.R.","""love boat"" hepatitis",1985,"Southern Medical Journal","78","9",,"1142","1143",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022120943&partnerID=40&md5=75e2ead27eba1d9bad71fb0207259167",Letter,Scopus,2-s2.0-0022120943
"Reddy, K.R., Gordon, S.C., Jeffers, L.J., Schiff, E.R.","Choledochocele: Its Clinical Spectrum",1985,"Gastroenterology","88","4",,"1093","",,,10.1016/S0016-5085(85)80059-7,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022052984&doi=10.1016%2fS0016-5085%2885%2980059-7&partnerID=40&md5=b28d9e11f01fe22a1949a95f54ceac24",Letter,Scopus,2-s2.0-0022052984
"Gordon, S.C., Reddy, K.R., Schiff, L., Schiff, E.R.","Prolonged intrahepatic cholestasis secondary to acute hepatitis A",1984,"Annals of Internal Medicine","101","5",,"635","637",,96,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021720429&partnerID=40&md5=367b6b02df63ee2a3c7c3678ea6f875d",Article,Scopus,2-s2.0-0021720429
"Gordon, S.C., Lauter, C.B.","Mumps arthritis: a review of the literature.",1984,"Reviews of Infectious Diseases","6","3",,"338","344",,21,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021436686&partnerID=40&md5=1576e3da4c7ebf92ead6afe2403971b0",Review,Scopus,2-s2.0-0021436686
"Gordon, S.C., Lauter, C.B.","Mumps arthritis: Unusual presentation as adult Still's disease",1982,"Annals of Internal Medicine","97","1",,"45","47",,24,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019986654&partnerID=40&md5=1e1636f8cd42e52addb879af4285c2bf",Article,Scopus,2-s2.0-0019986654
